Document:

Exhibit 10.2

 

Registration
Rights Agreement

 

This Registration Rights
Agreement (this “Agreement”) is made and entered into effective as of _______, 2016 (the “Effective
Date”) between Atrinsic, Inc., a Delaware corporation (the “Company”), and the persons who have executed
the signature page(s) hereto (each, a “Purchaser” and collectively, the “Purchasers”).

 

RECITALS:

 

WHEREAS, the Company
has entered into an Agreement and Plan of Merger with Protagenic Therapeutics Inc., a Delaware corporation (“PTI”),
pursuant to which a newly organized, wholly-owned subsidiary of the Company has merged with and into PTI, with PTI remaining as
the surviving entity and a wholly-owned subsidiary of the Company (the “Merger”);

 

WHEREAS, simultaneously
with the Merger and to provide the capital required by the Company for working capital and other purposes, the Company has offered
Series B Shares in compliance with Rule 506(b) of Regulation D and/or Regulation S of the Securities Act (as defined herein), to
investors in a private placement transaction (the “PPO”), pursuant to a Securities Purchase Agreement by and
among the parties hereto (the “Securities Purchase Agreement”; capitalized terms not defined herein shall have
the meanings ascribed to such terms in the Securities Purchase Agreement), Series B Shares, as well as a warrant (the “Placement
Agent Warrant”) to purchase Series B Shares (the “Placement Agent Shares”) issued to the placement agent
(the “Placement Agent”) in the PPO;

 

WHEREAS, the initial
closing of the PPO and the closing of the Merger have taken place on the Effective Date;

 

WHEREAS, in connection
with the Merger and the PPO, the Company agreed to provide certain registration rights related to the shares of Common Stock (the
“Investor Shares”) underlying the Series B Shares and the shares of Common Stock underlying the Series B Shares
issuable upon exercise of the Placement Agent Warrants, on the terms set forth herein;

 

WHEREAS, Brandt Mandia
has the right to have the shares of Common Stock (the “Mandia Shares”) underlying the Series B Shares issuable
upon the exercise of a warrant held by Brandt Mandia;

 

Now,
Therefore, in consideration of the mutual promises, representations, warranties, covenants, and conditions set forth herein,
the parties mutually agree as follows:

 

1.             Certain
Definitions. As used in this Agreement, the following terms shall have the following respective meanings:

 

“Allowed Delay”
has the meaning set forth in Section 3(f)(2).

 

“Approved
Market” means the Over-the-Counter Bulletin Board, the OTC Markets, the Pink Sheets, the Nasdaq Stock Market, the New
York Stock Exchange or the NYSE MKT.

 

    	 	1	 

     

    

 

“Blackout
Period” means, with respect to a registration, a period, in each case commencing on the day immediately after the Company
notifies the Purchasers that they are required, because of the occurrence of an event of the kind described in Section 4(f) hereof,
to suspend offers and sales of Registrable Securities during which the Company, in the good faith judgment of its board of directors,
determines (because of the existence of, or in anticipation of, any acquisition, financing activity, or other transaction involving
the Company, or the unavailability for reasons beyond the Company’s control of any required financial statements, disclosure
of information which is in its best interest not to publicly disclose, or any other event or condition of similar significance
to the Company) that the registration and distribution of the Registrable Securities to be covered by such Registration Statement,
if any, would be seriously detrimental to the Company and its stockholders and ending on the earlier of (1) the date upon which
the material non-public information commencing the Blackout Period is disclosed to the public or ceases to be material and (2)
such time as the Company notifies the selling Holders that the Company will no longer delay such filing of the Registration Statement,
recommence taking steps to make such Registration Statement effective, or allow sales pursuant to such Registration Statement to
resume.

 

“Business
Day” means any day of the year, other than a Saturday, Sunday, or other day on which the Commission is required or authorized
to close.

 

“Commission”
means the U. S. Securities and Exchange Commission or any other federal agency at the time administering the Securities Act.

 

“Common Stock”
means the common stock, par value $0.000001 per share, of the Company and any and all shares of capital stock or other equity securities
of: (i) the Company which are added to or exchanged or substituted for the Common Stock by reason of the declaration of any stock
dividend or stock split, the issuance of any distribution or the reclassification, readjustment, recapitalization or other such
modification of the capital structure of the Company; and (ii) any other corporation, now or hereafter organized under the laws
of any state or other governmental authority, with which the Company is merged, which results from any consolidation or reorganization
to which the Company is a party, or to which is sold all or substantially all of the shares or assets of the Company, if immediately
after such merger, consolidation, reorganization or sale, the Company or the stockholders of the Company own equity securities
having in the aggregate more than 50% of the total voting power of such other corporation.

 

“Effective
Date” has the meaning given it in the preamble to this Agreement.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission promulgated
thereunder.

 

“Family Member”
means (a) with respect to any individual, such individual’s spouse, any descendants (whether natural or adopted), any trust
all of the beneficial interests of which are owned by any of such individuals or by any of such individuals together with any organization
described in Section 501(c)(3) of the Internal Revenue Code of 1986, as amended, the estate of any such individual, and any corporation,
association, partnership or limited liability company all of the equity interests of which are owned by those above described individuals,
trusts or organizations and (b) with respect to any trust, the owners of the beneficial interests of such trust.

 

    	 	2	 

     

    

 

“Holder”
means each Purchaser (including, for purposes of this definition, each JBT Holder) or any of such Purchaser’s respective
successors and Permitted Assignees who acquire rights in accordance with this Agreement with respect to any Registrable Securities
directly or indirectly from a Purchaser or from any Permitted Assignee.

 

“Initial Registration
Statement” means the initial Registration Statement filed pursuant to this Agreement.

 

“Investor
Shares” has the meaning given it in the recitals of this Agreement.

 

“Majority
Holders” means at any time Holders representing a majority of the Registrable Securities.

 

“Mandia Shares”
has the meaning given it in the recitals of this Agreement.

 

“Permitted
Assignee” means (a) with respect to a partnership, its partners or former partners, (b) with respect to a corporation,
its stockholders, (c) with respect to a limited liability company, its members or former members, (d) with respect to an individual
party, any Family Member of such party, (e) an entity that is controlled by, controls, or is under common control with a transferor,
or (f) a party to this Agreement.

 

“Piggyback
Registration” means, in any registration of Common Stock as set forth in Section 3(b), the ability of holders of Registrable
Securities to include Registrable Securities in such registration.

 

“Placement
Agent” has the meaning given it in the recitals of this Agreement.

 

“Placement
Agent Warrant” has the meaning given it in the recitals of this Agreement.

 

The terms “register,”
“registered,” and “registration” refer to a registration effected by preparing and filing
a registration statement in compliance with the Securities Act, and the declaration or ordering of the effectiveness of such registration
statement.

 

“Registrable
Securities” means the Investor Shares and the Registrable Warrant Shares but excluding, subject to Section 3(e), (i)
any Registrable Securities that have been publicly sold or may be sold immediately without registration under the Securities Act
either pursuant to Rule 144(k) of the Securities Act or otherwise; (ii) any Registrable Securities sold by a person in a transaction
pursuant to a registration statement filed under the Securities Act, or (iii) any Registrable Securities that are at the time subject
to an effective registration statement under the Securities Act.

 

“Registrable
Warrant Shares” means the Mandia Shares and the shares of Common Stock underlying the Placement Agent Shares.

 

    	 	3	 

     

    

 

“Registration
Default Date” means the date that is 90 days after the date the Registration Statement is actually filed with the Commission.

 

“Registration
Filing Date” means the date that is 120 days after date of the final closing of the PPO.

 

“Registration
Statement” means the registration statement that the Company is required to file pursuant to this Agreement to register
the Registrable Securities.

 

“Rule 144”
means Rule 144 promulgated by the Commission under the Securities Act.

 

“Rule 145”
means Rule 145 promulgated by the Commission under the Securities Act.

 

“Rule 415”
means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time,
or any similar rule or regulation hereafter adopted by the SEC having substantially the same purpose and effect as such Rule.

 

“Securities
Act” means the Securities Act of 1933, as amended, or any similar federal statute promulgated in replacement thereof,
and the rules and regulations of the Commission thereunder, all as the same shall be in effect at the time.

 

“SEC Effective
Date” means the date the Registration Statement is declared effective by the Commission.

 

“Securities
Purchase Agreement” has the meaning given it in the recitals of this Agreement.

 

“Series B
Shares” has the meaning given it in the recitals of this Agreement.

 

“Trading Day”
means (a) if the Common Stock is listed or quoted on an Approved Market, then any day during which securities are generally eligible
for trading on the Approved Market, or (b) if the Common Stock is not then listed or quoted and traded on an Approved Market, then
any business day.

 

2.             Term.
This Agreement shall continue in full force and effect until the one (1) year anniversary of the SEC Effective Date, unless terminated
sooner hereunder.

 

3.             Registration.

 

(a)           Registration
on Form S-1. Not later than the Registration Filing Date, the Company shall file with the Commission a Registration Statement
on Form S-1, or other applicable form, relating to the resale by the Holders of all of the Registrable Securities, and the Company
shall use its commercially reasonably efforts to cause such Registration Statement to be declared effective prior to the Registration
Default Date.

 

    	 	4	 

     

    

 

(b)           Piggyback
Registration. In addition to the Company agreement pursuant to Section 3(a) above, if the Company shall determine to register
for sale for cash any of its Common Stock, for its own account or for the account of others (other than the Holders), other than
(i) a registration relating solely to employee benefit plans or securities issued or issuable to employees, consultants (to the
extent the securities owned or to be owned by such consultants could be registered on Form S-8) or any of their Family Members
(including a registration on Form S-8) or (ii) a registration relating solely to a Securities Act Rule 145 transaction or a registration
on Form S-4 in connection with a merger, acquisition, divestiture, reorganization or similar event, the Company shall promptly
give to the Holders written notice thereof (and in no event shall such notice be given less than 20 calendar days prior to the
filing of such registration statement), and shall, subject to Section 3(c), include as a Piggyback Registration all of the Registrable
Securities specified in a written request delivered by the Holder thereof within 10 calendar days after receipt of such written
notice from the Company. However, the Company may, without the consent of the Holders, withdraw such registration statement prior
to its becoming effective if the Company or such other stockholders have elected to abandon the proposal to register the securities
proposed to be registered thereby.

 

(c)           Underwriting.
If a Piggyback Registration is for a registered public offering that is to be made by an underwriting, the Company shall so advise
the Holders of the Registrable Securities eligible for inclusion in such Registration Statement pursuant to Sections 3(b). In that
event, the right of any Holder to Piggyback Registration shall be conditioned upon such Holder’s participation in such underwriting
and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided herein. All Holders
proposing to sell any of their Registrable Securities through such underwriting shall (together with the Company and any other
stockholders of the Company selling their securities through such underwriting) enter into an underwriting agreement in customary
form with the underwriter selected for such underwriting by the Company or the selling stockholders, as applicable. Notwithstanding
any other provision of this Section, if the underwriter or the Company determines that marketing factors require a limitation on
the number of shares of Common Stock or the amount of other securities to be underwritten, the underwriter may exclude some or
all Registrable Securities from such registration and underwriting. The Company shall so advise all Holders (except those Holders
who failed to timely elect to include their Registrable Securities through such underwriting or have indicated to the Company their
decision not to do so), and indicate to each such Holder the number of shares of Registrable Securities that may be included in
the registration and underwriting, if any. The number of shares of Registrable Securities to be included in such registration and
underwriting shall be allocated among such Holders as follows:

 

(i)          If
the Piggyback Registration was initiated by the Company, the number of shares that may be included in the registration and underwriting
shall be allocated first to the Company and then, subject to obligations and commitments existing as of the date hereof, to all
selling stockholders, including the Holders, who have requested to sell in the registration on a pro rata basis according to the
number of shares requested to be included therein; and

 

(ii)         If
the Piggyback Registration was initiated by the exercise of demand registration rights by a stockholder or stockholders of the
Company (other than the Holders), then the number of shares that may be included in the registration and underwriting shall be
allocated first to such selling stockholders who exercised such demand and then, subject to obligations and commitments existing
as of the date hereof, to all other selling stockholders, including the Holders, who have requested to sell in the registration
on a pro rata basis according to the number of shares requested to be included therein.

 

    	 	5	 

     

    

 

No Registrable Securities
excluded from the underwriting by reason of the underwriter’s marketing limitation shall be included in such registration
and no liquidated damages as set forth in Section 3(d) shall accrue with respect to such excluded securities. If any Holder disapproves
of the terms of any such underwriting, such Holder may elect to withdraw such Holder’s Registrable Securities therefrom by
delivering a written notice to the Company and the underwriter. The Registrable Securities so withdrawn from such underwriting
shall also be withdrawn from such registration; provided, however, that, if by the withdrawal of such Registrable
Securities, a greater number of Registrable Securities held by other Holders may be included in such registration (up to the maximum
of any limitation imposed by the underwriters), then the Company shall offer to all Holders who have included Registrable Securities
in the registration the right to include additional Registrable Securities pursuant to the terms and limitations set forth herein
in the same proportion used above in determining the underwriter limitation.

 

(d)           [Intentionally
Omitted]

 

(e)           Cutbacks:

 

(1)(a) if the Commission
does not declare the Registration Statement effective on or before the Registration Default Date, or (b) if the Commission allows
the Registration Statement to be declared effective at any time before or after the Registration Default Date, subject to the withdrawal
of certain Registrable Securities from the Registration Statement, and the reason for (a) or (b) is the Commission’s determination
that (x) the offering of any of the Registrable Securities constitutes a primary offering of securities by the Company, (y) Rule
415 may not be relied upon for the registration of the resale of any or all of the Registrable Securities, and/or (z) a Holder
of any Registrable Securities must be named as an underwriter, the Holders understand and agree that in the case of (b) the Company
may reduce, on a pro rata basis, the total number of Registrable Securities to be registered on behalf of each such Holder.
In any such pro rata reduction, the number of Registrable Securities to be registered on such Registration Statement will
first be reduced by (i) first, the Registrable Securities represented by the Registrable Warrant Shares (applied, in the case that
some Registrable Warrant Shares may be registered, to the Holders on a pro rata basis based on the total number of unregistered
Registrable Warrant Shares held by such Holders on a fully diluted basis), and (ii) second, Registrable Securities represented
by Investor Shares (applied, in the case that some Investor Shares may be registered, to the Holders on a pro rata basis
based on the total number of unregistered Investor Shares held by such Holders). In addition,
any such affected Holder shall be entitled to Piggyback Registration rights after the Registration Statement is declared effective
by the Commission until such time as: (AA) all Registrable Securities have been registered pursuant to an effective Registration
Statement, (BB) the Registrable Securities may be resold without restriction pursuant to Rule 144 of the Securities Act, or (CC)
the Holder agrees to be named as an underwriter in any such registration statement. The Holders acknowledge and agree the provisions
of this paragraph may apply to more than one Registration Statement; and

 

    	 	6	 

     

    

 

(2)            For
not more than fifteen (15) consecutive days or for a total of not more than thirty (30) days in any twelve (12) month period, the
Company may suspend the use of any prospectus included in any Registration Statement contemplated by this Section in the event
that the Company determines in good faith that such suspension is necessary to (A) delay the disclosure of material non-public
information concerning the Company, the disclosure of which at the time is not, in the good faith opinion of the Company, in the
best interests of the Company or (B) amend or supplement the affected Registration Statement or the related prospectus so that
such Registration Statement or prospectus shall not include an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein, in the case of the prospectus in light of the circumstances
under which they were made, not misleading, including in connection with the filing of a post-effective amendment to such Registration
Statement in connection with the Company’s filing of an Annual Report on Form 10-K for any fiscal year (an “Allowed
Delay”); provided, that the Company shall promptly (a) notify each Holder in writing of the commencement of an Allowed
Delay, but shall not (without the prior written consent of an Holder) disclose to such Holder any material non-public information
giving rise to an Allowed Delay, (b) advise the Holders in writing to cease all sales under the Registration Statement until the
end of the Allowed Delay and (c) use commercially reasonable efforts to terminate an Allowed Delay as promptly as practicable.

 

4.             Registration
Procedures for Registrable Securities. The Company will keep each Holder reasonably advised as to the filing and effectiveness
of the Registration Statement. At its expense with respect to the Registration Statement, the Company will:

 

(a)           prepare
and file with the Commission with respect to the Registrable Securities, a Registration Statement on Form S-1, or any other form
for which the Company then qualifies or which counsel for the Company shall deem appropriate and which form shall be available
for the sale of the Registrable Securities in accordance with the intended methods of distribution thereof, and use its commercially
reasonable efforts to cause such Registration Statement to become effective and shall remain effective for a period of one year
or for such shorter period ending on the earlier to occur of (i) the date as of which all of the Holders as selling stockholders
thereunder may sell all of the Registrable Securities registered for resale thereon without restriction pursuant to Rule 144 (or
any successor rule thereto) promulgated under the Securities Act or (ii) the date when all of the Registrable Securities registered
thereunder shall have been sold (the “Effectiveness Period”). Thereafter, the Company shall be entitled
to withdraw such Registration Statement and the Purchasers shall have no further right to offer or sell any of the Registrable
Securities registered for resale thereon pursuant to the respective Registration Statement (or any prospectus relating thereto);

 

(b)           if
the Registration Statement is subject to review by the Commission, respond in a commercially reasonable manner to all comments
and diligently pursue resolution of any comments to the satisfaction of the Commission;

 

(c)           prepare
and file with the Commission such amendments and supplements to such Registration Statement as may be necessary to keep such Registration
Statement effective during the Effectiveness Period;

 

    	 	7	 

     

    

 

(d)           furnish,
without charge, to each Holder of Registrable Securities covered by such Registration Statement (i) a reasonable number of copies
of such Registration Statement (including any exhibits thereto other than exhibits incorporated by reference), each amendment and
supplement thereto as such Holder may reasonably request, (ii) such number of copies of the prospectus included in such Registration
Statement (including each preliminary prospectus and any other prospectus filed under Rule 424 of the Securities Act) as such Holders
may reasonably request, in conformity with the requirements of the Securities Act, and (iii) such other documents as such Holder
may require to consummate the disposition of the Registrable Securities owned by such Holder, but only during the Effectiveness
Period;

 

(e)           use
its commercially reasonable efforts to register or qualify such registration under such other applicable securities laws of such
jurisdictions as any Holder of Registrable Securities covered by such Registration Statement reasonably requests and as may be
necessary for the marketability of the Registrable Securities (such request to be made by the time the applicable Registration
Statement is deemed effective by the Commission) and do any and all other acts and things necessary to enable such Holder to consummate
the disposition in such jurisdictions of the Registrable Securities owned by such Holder; provided, that the Company shall
not be required to (i) qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify
but for this paragraph, (ii) subject itself to taxation in any such jurisdiction, or (iii) consent to general service of process
in any such jurisdiction.

 

(f)            notify
each Holder of Registrable Securities, the disposition of which requires delivery of a prospectus relating thereto under the Securities
Act, of the happening of any event (as promptly as practicable after becoming aware of such event), which comes to the Company’s
attention, that will after the occurrence of such event cause the prospectus included in such Registration Statement, if not amended
or supplemented, to contain an untrue statement of a material fact or an omission to state a material fact required to be stated
therein or necessary to make the statements therein not misleading and the Company shall promptly thereafter prepare and furnish
to such Holder a supplement or amendment to such prospectus (or prepare and file appropriate reports under the Exchange Act) so
that, as thereafter delivered to the purchasers of such Registrable Securities, such prospectus shall not contain an untrue statement
of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein
not misleading, unless suspension of the use of such prospectus otherwise is authorized herein or in the event of a Blackout Period,
in which case no supplement or amendment need be furnished (or Exchange Act filing made) until the termination of such suspension
or Blackout Period;

 

(g)           comply,
and continue to comply during the Effectiveness Period, in all material respects with the Securities Act and the Exchange Act and
with all applicable rules and regulations of the Commission with respect to the disposition of all securities covered by such Registration
Statement;

 

(h)           as
promptly as practicable after becoming aware of such event, notify each Holder of Registrable Securities being offered or sold
pursuant to the Registration Statement of the issuance by the Commission of any stop order or other suspension of effectiveness
of the Registration Statement;

 

    	 	8	 

     

    

 

(i)            use
its commercially reasonable efforts to cause all the Registrable Securities covered by the Registration Statement to be quoted
on the OTC Bulletin Board or such other Approved Market on which securities of the same class or series issued by the Company are
then listed or traded;

 

(j)            provide
a transfer agent and registrar, which may be a single entity, for the shares of Common Stock at all times;

 

(k)           if
requested by the Holders, cooperate with the Holders to facilitate the timely preparation and delivery of certificates representing
Registrable Securities to be delivered to a transferee pursuant to the Registration Statement, which certificates shall be free,
to the extent permitted by applicable law, of all restrictive legends, and to enable such Registrable Securities to be in such
denominations and registered in such names as any such Holders may request;

 

(l)            during
the Effectiveness Period, refrain from bidding for or purchasing any Common Stock or any right to purchase Common Stock or attempting
to induce any person to purchase any such security or right if such bid, purchase or attempt would in any way limit the right of
the Holders to sell Registrable Securities by reason of the limitations set forth in Regulation M of the Exchange Act; and

 

(m)           take
all other reasonable actions necessary to expedite and facilitate the disposition by the Holders of the Registrable Securities
pursuant to the Registration Statement.

 

5.             Suspension
of Offers and Sales. Each Holder agrees that, upon receipt of any notice from the Company of the happening of any event of
the kind described in Section 4(f) hereof or of the commencement of a Blackout Period, such Holder shall discontinue the disposition
of Registrable Securities included in the Registration Statement until such Holder’s receipt of the copies of the supplemented
or amended prospectus contemplated by Section 4(f) hereof or notice of the end of the Blackout Period, and, if so directed by the
Company, such Holder shall deliver to the Company (at the Company’s expense) all copies (including, without limitation, any
and all drafts), other than permanent file copies, then in such Holder’s possession, of the prospectus covering such Registrable
Securities current at the time of receipt of such notice.

 

6.             Registration
Expenses. The Company shall pay all expenses in connection with any registration obligation provided herein, including, without
limitation, all registration, filing, stock exchange fees, printing expenses, all fees and expenses of complying with applicable
securities laws, and the fees and disbursements of counsel for the Company and of its independent accountants; provided,
that, in any registration, each party shall pay for its own underwriting discounts and commissions and transfer taxes. Except as
provided in this Section and Section 9, the Company shall not be responsible for the expenses of any attorney or other advisor
employed by a Holder.

 

    	 	9	 

     

    

 

7.             Assignment
of Rights. No Holder may assign its rights under this Agreement to any party without the prior written consent of the Company;
provided, however, that any Holder may assign its rights under this Agreement without such consent to a Permitted
Assignee as long as (a) such transfer or assignment is effected in accordance with applicable securities laws; (b) such transferee
or assignee agrees in writing to become subject to the terms of this Agreement; and (c) such Holder notifies the Company in writing
of such transfer or assignment, stating the name and address of the transferee or assignee and identifying the Registrable Securities
with respect to which such rights are being transferred or assigned.

 

8.             Information
by Holder. A Holder of Registrable Securities included in any registration shall furnish to the Company such information regarding
itself, the Registrable Securities held by it, and the intended method of disposition of such securities as shall be required in
order to comply with any applicable law or regulation in connection with the registration of such Holder’s Registrable Securities
or any qualification or compliance with respect to such Holder’s Registrable Securities and referred to in this Agreement.

 

9.             Indemnification.

 

(a)           In
the event of the offer and sale of Registrable Securities under the Securities Act, the Company shall, and hereby does, indemnify
and hold harmless, to the fullest extent permitted by law, each Holder, its directors, officers, partners, each other person who
participates as an underwriter in the offering or sale of such securities, and each other person, if any, who controls or is under
common control with such Holder or any such underwriter within the meaning of Section 15 of the Securities Act, against any losses,
claims, damages or liabilities, joint or several, and expenses to which the Holder or any such director, officer, partner or underwriter
or controlling person may become subject under the Securities Act, the Exchange Act, or any other federal or state law, insofar
as such losses, claims, damages, liabilities or expenses (or actions or proceedings, whether commenced or threatened, in respect
thereof) arise out of or are based upon any untrue statement of any material fact contained in any registration statement prepared
and filed by the Company under which Registrable Securities were registered under the Securities Act, any preliminary prospectus,
final prospectus or summary prospectus contained therein, or any amendment or supplement thereto, or any omission to state therein
a material fact required to be stated or necessary to make the statements therein in light of the circumstances in which they were
made not misleading, or any violation or alleged violation of the Securities Act, the Exchange Act, any state securities law or
any rule or regulation promulgated under the Securities Act, the Exchange Act or any state securities law in connection with this
Agreement; and the Company shall reimburse the Holder, and each such director, officer, partner, underwriter and controlling person
for any legal or any other expenses reasonably incurred by them in connection with investigating, defending or settling any such
loss, claim, damage, liability, action or proceeding; provided, that such indemnity agreement found in this Section 9(a)
shall in no event exceed the net proceeds from the PPO received by the Company; and provided further, that the Company shall
not be liable in any such case to the extent that any such loss, claim, damage, liability (or action or proceeding in respect thereof)
or expense arises out of or is based upon an untrue statement in or omission from such registration statement, any such preliminary
prospectus, final prospectus, summary prospectus, amendment or supplement in reliance upon and in conformity with written information
furnished to the Company by the Holder specifically for use in the preparation thereof. Such indemnity shall remain in full force
and effect regardless of any investigation made by or on behalf of the Holders, or any such director, officer, partner, underwriter
or controlling person and shall survive the transfer of such shares by the Holder.

 

    	 	10	 

     

    

 

(b)           As
a condition to including Registrable Securities in any registration statement filed pursuant to this Agreement, each Holder agrees
to be bound by the terms of this Section 9 and to indemnify and hold harmless, to the fullest extent permitted by law, the Company,
its directors and officers, and each other person, if any, who controls the Company within the meaning of Section 15 of the Securities
Act, against any losses, claims, damages or liabilities, joint or several, to which the Company or any such director or officer
or controlling person may become subject under the Securities Act, the Exchange Act, or any other federal or state law, to the
extent arising out of or based solely upon: any untrue or alleged untrue statement of a material fact contained in any registration
statement, any prospectus, or any form of prospectus, or in any amendment or supplement thereto or in any preliminary prospectus,
or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary
to make the statements therein not misleading (i) to the extent, but only to the extent, that such untrue statement or omission
is contained in any information so furnished in writing by such Holder to the Company specifically for inclusion in the registration
statement or such prospectus or (ii) to the extent that (1) such untrue statements or omissions are based solely upon information
regarding such Holder furnished in writing to the Company by such Holder expressly for use therein, or to the extent that such
information relates to such Holder or such Holder’s proposed method of distribution of Registrable Securities and was reviewed
and expressly approved in writing by such Holder expressly for use in the Registration Statement, such prospectus or such form
of prospectus or in any amendment or supplement thereto or (2) in the case of an occurrence of an event of the type specified in
Section 4(f) hereof, the use by such Holder of an outdated or defective prospectus after the Company has notified such Holder in
writing that the prospectus is outdated or defective and prior to the receipt by such Holder of the advice contemplated in Section
4(f). In no event shall the liability of any selling Holder hereunder be greater in amount than the dollar amount of the net proceeds
received by such Holder upon the sale of the Registrable Securities giving rise to such indemnification obligation.

 

(c)           Promptly
after receipt by an indemnified party of notice of the commencement of any action or proceeding involving a claim referred to in
this Section (including any governmental action), such indemnified party shall, if a claim in respect thereof is to be made against
an indemnifying party, give written notice to the indemnifying party of the commencement of such action; provided, that
the failure of any indemnified party to give notice as provided herein shall not relieve the indemnifying party of its obligations
under this Section, except to the extent that the indemnifying party is actually prejudiced by such failure to give notice. In
case any such action is brought against an indemnified party, unless in the reasonable judgment of counsel to such indemnified
party a conflict of interest between such indemnified and indemnifying parties may exist or the indemnified party may have defenses
not available to the indemnifying party in respect of such claim, the indemnifying party shall be entitled to participate in and
to assume the defense thereof, with counsel reasonably satisfactory to such indemnified party and, after notice from the indemnifying
party to such indemnified party of its election so to assume the defense thereof, the indemnifying party shall not be liable to
such indemnified party for any legal or other expenses subsequently incurred by the latter in connection with the defense thereof,
unless in such indemnified party’s reasonable judgment a conflict of interest between such indemnified and indemnifying parties
arises in respect of such claim after the assumption of the defenses thereof or the indemnifying party fails to defend such claim
in a diligent manner, other than reasonable costs of investigation. Neither an indemnified nor an indemnifying party shall be liable
for any settlement of any action or proceeding effected without its consent. No indemnifying party shall, without the consent of
the indemnified party, consent to entry of any judgment or enter into any settlement, which does not include as an unconditional
term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect of such
claim or litigation. Notwithstanding anything to the contrary set forth herein, and without limiting any of the rights set forth
above, in any event any party shall have the right to retain, at its own expense, counsel with respect to the defense of a claim.

 

    	 	11	 

     

    

 

(d)           If
the indemnification provided for in Section 9(a) or 9(b) is held by a court of competent jurisdiction to be unavailable to an indemnified
party with respect to any loss, liability, claim, damage or expense referred to herein, the indemnifying party, in lieu of indemnifying
such indemnified party hereunder, shall (i) contribute to the amount paid or payable by such indemnified party as a result of such
loss, liability, claim, damage or expense as is appropriate to reflect the proportionate relative fault of the indemnifying party
on the one hand and the indemnified party on the other (determined by reference to, among other things, whether the untrue or alleged
untrue statement of a material fact or omission relates to information supplied by the indemnifying party or the indemnified party
and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such untrue statement
or omission), or (ii) if the allocation provided by clause (i) above is not permitted by applicable law or provides a lesser sum
to the indemnified party than the amount hereinafter calculated, not only the proportionate relative fault of the indemnifying
party and the indemnified party, but also the relative benefits received by the indemnifying party on the one hand and the indemnified
party on the other, as well as any other relevant equitable considerations. No indemnified party guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any indemnifying party who was
not guilty of such fraudulent misrepresentation.

 

(e)           Other
Indemnification. Indemnification similar to that specified in this Section (with appropriate modifications) shall be given
by the Company and each Holder of Registrable Securities with respect to any required registration or other qualification of securities
under any federal or state law or regulation or governmental authority other than the Securities Act.

 

10.           Rule
144. With a view to making available to the Holders the benefits of Rule 144 and any other rule or regulation of the Commission
that may at any time permit the Holders to sell the Registrable Securities to the public without registration, the Company agrees:
(i) to make and keep public information available as those terms are understood in Rule 144, (ii) to file with the Commission in
a timely manner all reports and other documents required to be filed by an issuer of securities registered under the Securities
Act or the Exchange Act pursuant to Rule 144, (iii) as long as any Holder owns any Registrable Securities, to furnish in writing
upon such Holder’s request a written statement by the Company that it has complied with the reporting requirements of Rule
144 and of the Securities Act and the Exchange Act, and to furnish to such Holder a copy of the most recent annual or quarterly
report of the Company, and such other reports and documents so filed by the Company as may be reasonably requested in availing
such Holder of any rule or regulation of the Commission permitting the selling of any such Registrable Securities without registration
and (iv) undertake any additional actions commercially reasonably necessary to maintain the availability of the use of Rule 144.

 

    	 	12	 

     

    

 

11.           Independent
Nature of Each Purchaser’s Obligations and Rights. The obligations of each Purchaser under this Agreement are several
and not joint with the obligations of any other Purchaser, and each Purchaser shall not be responsible in any way for the performance
of the obligations of any other Purchaser under this Agreement. Nothing contained herein and no action taken by any Purchaser pursuant
hereto, shall be deemed to constitute such Purchasers as a partnership, an association, a joint venture, or any other kind of entity,
or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or
the transactions contemplated by this Agreement. Each Purchaser shall be entitled to independently protect and enforce its rights,
including without limitation the rights arising out of this Agreement, and it shall not be necessary for any other Purchaser to
be joined as an additional party in any proceeding for such purpose.

 

12.           Other
Registration Rights. The Company shall not grant any additional registration rights other than those contemplated herein without
the consent of the Majority Holders prior to the effectiveness of the Registration Statement other than, in the case of the Company
(i) a registration relating solely to employee benefit plans or securities issued or issuable to employees, consultants (to the
extent the securities owned or to be owned by such consultants could be registered on Form S-8) or any of their Family Members
(including a registration on Form S-8) or (ii) a registration on Form S-4 or Form F-4 in connection with a merger, acquisition,
divestiture, reorganization or similar event.

 

13.           Miscellaneous.

 

(a)           Governing
Law. This Agreement shall be governed by and construed in accordance with the laws of the United States of America and the
State of New York, both substantive and remedial, without regard to New York conflicts of law principles. Any judicial proceeding
brought against either of the parties to this Agreement or any dispute arising out of this Agreement or any matter related hereto
shall be brought in the courts of the State of New York, New York County, or in the United States District Court for the Southern
District of New York and, by its execution and delivery of this Agreement, each party to this Agreement accepts the jurisdiction
of such courts. The foregoing consent to jurisdiction shall not be deemed to confer rights on any person other than the parties
to this Agreement.

 

(b)           Remedies.
In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement, each Holder
or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement,
including recovery of damages, shall be entitled to specific performance of its rights under this Agreement. The Company and each
Holder agree that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it
of any of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance
in respect of such breach, it shall not assert or shall waive the defense that a remedy at law would be adequate.

 

    	 	13	 

     

    

 

(c)           Successors
and Assigns. Except as otherwise provided herein, the provisions hereof shall inure to the benefit of, and be binding upon,
the successors, Permitted Assignees, executors and administrators of the parties hereto.

 

(d)           No
Inconsistent Agreements. The Company has not entered, as of the date hereof, and shall not enter, on or after the date of this
Agreement, into any agreement with respect to its securities that would have the effect of impairing the rights granted to the
Holders in this Agreement or otherwise conflicts with the provisions hereof.

 

(e)           Entire
Agreement. This Agreement constitutes the full and entire understanding and agreement between the parties with regard to the
subjects hereof.

 

(f)            Notices,
etc. All notices or other communications which are required or permitted under this Agreement shall be in writing and sufficient
if delivered by hand, by facsimile transmission, by registered or certified mail, postage pre-paid, by electronic mail, or by courier
or overnight carrier, to the persons at the addresses set forth below (or at such other address as may be provided hereunder),
and shall be deemed to have been delivered as of the date so delivered:

 

If to the Company to:

 

Atrinsic, Inc.

(or to Protagenic Therapeutics Holdings, Inc., following
the Reverse Stock Split)

149 Fifth Avenue, Suite 500

New York, NY 10010

Attn: Alex Arrow, CFO

E-mail: alex.arrow@protagenic.com

 

with copy to:

 

Meister Seelig & Fein LLP

125 Park Avenue, 7th Floor

New York, NY 10017

Attn: Kenneth S. Goodwin, Esq.

Facsimile: (646) 539 3663

 

If to the Purchasers:

 

To each Purchaser at the address set forth
on the signature page hereto or at such other address as any party shall have furnished to the other parties in writing.

 

(g)           Delays
or Omissions. No delay or omission to exercise any right, power or remedy accruing to any Holder, upon any breach or default
of the Company under this Agreement, shall impair any such right, power or remedy of such Holder nor shall it be construed to be
a waiver of any such breach or default, or an acquiescence therein, or of any similar breach or default thereunder occurring; nor
shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring.
Any waiver, permit, consent or approval of any kind or character on the part of any Holder of any breach or default under this
Agreement, or any waiver on the part of any Holder of any provisions or conditions of this Agreement, must be in writing and shall
be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement, or by law or
otherwise afforded to any holder, shall be cumulative and not alternative.

 

    	 	14	 

     

    

 

(h)           Counterparts.
This Agreement may be executed in any number of counterparts, each of which shall be enforceable against the parties actually executing
such counterparts, and all of which together shall constitute one instrument. In the event that any signature is delivered by facsimile
transmission or electronic transmission via .PDF file, such signature shall create a valid and binding obligation of the party
executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or electronic signature
page were an original thereof.

 

(i)            Severability.
In the case any provision of this Agreement shall be invalid, illegal or unenforceable, the validity, legality and enforceability
of the remaining provisions shall not in any way be affected or impaired thereby.

 

(j)            Amendments.
The provisions of this Agreement may be amended at any time and from time to time, and particular provisions of this Agreement
may be waived, with and only with an agreement or consent in writing signed by the Company and the Majority Holders. The Purchasers
acknowledge that by the operation of this Section, the Majority Holders may have the right and power to diminish or eliminate all
rights of the Purchasers under this Agreement.

 

[SIGNATURE PAGES FOLLOW]

 

    	 	15	 

     

    

 

This Registration Rights
Agreement is hereby executed as of the date first above written.

 

	 	COMPANY:
	 	 
	 	ATRINSIC, INC.
	 	 	 
	 	By: 	 
	 	Name: 	Garo H. Armen 
	 	Title:	Chairman

 

EACH PURCHASER’S
SIGNATURE TO THE OMNIBUS SIGNATURE PAGE TO THE SECURITIES PURCHASE AGREEMENT DATED OF EVEN DATE HEREWITH SHALL CONSTITUTE THE PURCHASER’S
SIGNATURE TO THIS REGISTRATION RIGHTS AGREEMENT.

 

    	 	16Exhibit 10.3

 

KATALYST
SECURITIES LLC

15 MAIDEN LANE,
ROOM 601

NEW YORK, NY
10038

TEL: 212-587-6667

Member: FINRA
& SIPC

 

PLACEMENT
AGENCY AGREEMENT

 

January 25,
2016

 

Mr. Edward Gildea

Chief Executive Officer

Atrinsic, Inc.

65 Atlantic Avenue

Boston, MA 02110

 

		Re:	Private placement offering
of up to $4 million

of
Series B Preferred Stock 

 

Dear Mr. Gildea:

 

This
Placement Agency Agreement (“Agreement”) sets forth the terms upon which Katalyst Securities LLC (“Katalyst”),
registered broker-dealer and member of the Financial Industry Regulatory Authority (“FINRA”) (hereinafter referred
to as the “Placement Agent”), shall be engaged by Atrinsic, Inc., a
publicly traded Delaware Corporation (hereinafter referred to
as the “Company”), to act as exclusive Placement Agent in connection with the private placement (the “Offering”)
of the securities of the Company (the “Securities”). The initial closing of the Offering will be conditioned upon
and acceptance of subscriptions for the Minimum Amount (as defined below) and the consummation of a reverse triangular merger
(the “Merger”) by and among a subsidiary of the Company, Protagenic Therapeutics Inc. (“PTI”),
a privately held Delaware corporation, and the Company and certain other transactions described herein, pursuant to which PTI
will become a wholly owned subsidiary of the Company, and all of the
outstanding PTI stock will be converted into shares of the Company’s
Preferred Stock (as such term is defined below).

 

1.             Appointment
of Placement Agent.

 

(a)           On
the basis of the written and documented representations and warranties of the Company provided herein, and subject to the terms
and conditions set forth herein, the Placement Agent is hereby appointed as an exclusive Placement Agent of the Company during
the Offering Period (as defined in Section 3(b) below) to assist the Company in finding qualified subscribers for the Offering.
The Placement Agent may sell the Securities through other broker-dealers who are FINRA members (collectively, the “Sub Agents”)
and may reallow all or a portion of the Brokers’ Fees (as defined in Section 3(a) and 3(b) below) it receives to such other
Sub Agents or pay a finders or consultant fee as allowed by applicable law. On the basis of such representations and warranties
and subject to such terms and conditions, the Placement Agent hereby accepts such appointment and agrees to perform the services
hereunder diligently and in good faith and in a professional and businesslike manner and in compliance with applicable law and
to use its reasonable best efforts to assist the Company in finding subscribers of the Securities who qualify as “accredited
investors,” as such term is defined in Rule 501 of Regulation D. The Placement Agent has no obligation to purchase any of
the Securities or sell any Securities. Unless sooner terminated in accordance with this Agreement, the engagement of the Placement
Agent hereunder shall continue until the later of the Termination Date or the Final Closing (as defined below). The Offering is
currently anticipated to be the private placement of a minimum of gross proceeds of $3,350,000 (the “Minimum Offering”)
and a maximum of gross proceeds of $4,000,000 (the “Maximum Offering”) through the sale of Series B Preferred Stock,
par value $0.000001 per share, of the Company (the “Preferred Stock”),
at the Purchase Price of $1.25 per share (the “Offering Price”). The minimum subscription is Twenty Five Thousand
Dollars ($25,000), Twenty Thousand (20,000 shares), provided, however, that subscriptions in lesser amounts may be accepted
by the Company in its sole discretion.

 

    	Placement Agency Agreement (PIPE)	Page 1

     

    

 

(b)           The
Placement Agent is engaged to raise a minimum of One Million Dollars ($1,000,000) (the “Minimum Raise”) and a maximum
of One Million Six Hundred Fifty Thousand Dollars ($1,650,000) (the “Maximum
Raise”) of Securities out of the total Offering, on a reasonable best efforts basis. This Maximum Raise may be increased
at the sole discretion of the Company by an aggregate of One Million Five Hundred Thousand
Dollars ($1,500,000). The Company agrees and acknowledges that the Placement Agent is not acting as an underwriter with
respect to the Offering and the Company shall determine the purchasers in the Offering in its sole discretion. The Securities
will be offered by the Company to potential subscribers, which may include related parties of the Placement Agent or the Company,
commencing on February 29, 2016 (the “Initial Offering Period”),
which date may be extended by the Company through April 15, 2016 (this additional
period and the Initial Offering Period shall be referred to as the “Offering Period”). The date on which the Offering
is terminated shall be referred to as the “Termination Date”. The closing of the Offering may be held up to ten days
after the Termination Date. 

 

(c)            The
Company shall only offer securities to and accept subscriptions from or sell Securities to, persons or entities that qualify as
(or are reasonably believed to be) “accredited investors,” as such term is defined in Rule 501 of Regulation D (“Regulation
D”) as promulgated by the United States Securities and Exchange Commission (the “SEC”) under Section 4(a)(2)
of the Securities Act of 1933, as amended (the “Act”).

 

(d)           The
offering of Securities will be made by the Placement Agent on behalf of the Company solely pursuant to the Subscription Agreement
and the Exhibits to the Subscription Agreement, including, but not limited to, and to the extent applicable, the Summary Term
Sheet, Registration Rights Agreement, a draft of the Form 8-K relating to the Merger and the business of PTI to be filed by the
Company with the Securities and Exchange Commission (the “Super 8-K”) and the risk factors and disclosures will be
available to the Placement Agent prior to such filing, and any documents, agreements,
supplements and additions thereto (collectively, the “Subscription Documents”), which at all times will be in form
and substance reasonably acceptable to the Company and the Placement Agent and their respective counsel and contain such legends
and other information as the Company and the Placement Agent and their respective counsel, may, from time to time, deem necessary
and desirable to be set forth therein.

 

(e)           With
respect to the Offering, the Company shall provide the Placement Agent, on terms set forth herein, the right to offer and sell
all up to the Maximum Raise of available Securities being offered during the Offering Period (subject to prior offer and sale
of some of the Securities). It is understood that no sale shall be regarded as effective unless and until accepted by the Company.
The Company may, in its sole discretion, accept or reject, in whole or in part,
any prospective investment in the Securities or allot to any prospective subscriber less than the number of Securities that such
subscriber desires to purchase. Purchases of Securities may be made by the Placement Agent and its selected sub-dealers and their
respective officers, directors, employees and affiliates and by the officers, directors, employees and affiliates of the Company
and PTI (collectively, the “Affiliates”) for the Offering and such purchases will be made by the Affiliates based
solely upon the same information that is provided to the investors in the Offering.

 

    	Placement Agency Agreement (PIPE)	Page 2

     

    

 

2.            Representations,
Warranties and Covenants.

 

A.            Representations,
Warranties and Covenants of the Company. The Company hereby represents and warrants to the Placement Agent that, except as
otherwise set forth in the disclosure schedule provided by the Company to the Placement Agent on the date hereof and as updated,
if necessary, by the Company immediately prior to the closing of the transactions contemplated hereby, and collectively attached
hereto as Exhibit A (the “Company Disclosure Schedule”), and assuming that the conditions described in Section
6 hereof are satisfied, each of the representations and warranties contained in this Section 2 is true in all respects as of the
date hereof and will be true in all respects as of the Closing Date and any subsequent Closing Dates (which will be deemed to
be following the closing of the Merger), as defined under Section 4(e). In addition to the representations and warranties set
forth herein, the Placement Agent shall be entitled to rely upon the representations and warranties made or given by the Company
to any acquirer of Securities in the Offering in any agreement, certificate, legal opinion or otherwise in connection with an
Offering. For purposes of this Section 2(A), the term Company includes all of the Company’s subsidiaries (if any).

 

(a)          The
Subscription Documents have been and/or will be prepared by the Company, in conformity with all applicable laws, and in compliance
with Regulation D and/or Section 4(a)(2) of the Act and the requirements of
all other rules and regulations (the “Regulations”) of the SEC relating to offerings of the type contemplated by the
Offering, and the applicable securities laws and the rules and regulations of those jurisdictions wherein the Placement Agent
notifies the Company that the Securities are to be offered and sold (including U.S. states). The Securities will be offered and
sold pursuant to the registration exemption provided by Regulation D and/or Section 4(a)(2)
of the Act as a transaction not involving a public offering and the requirements of any other applicable state securities laws
and the respective rules and regulations thereunder in those United States jurisdictions in which the Placement Agent notifies
the Company that the Securities are being offered for sale. None of the Company, its affiliates, or any person acting on its or
their behalf (other than the Placement Agent, its respective affiliates or any person acting on their behalf, in respect of which
no representation is made) has taken nor will it take any action that conflicts with the conditions and requirements of, or that
would make unavailable with respect to the Offering, the exemption(s) from registration available pursuant to Rule 506 of Regulation
D and/or Section 4(a)(2) of the Act and applicable state securities laws, or
knows of any reason why any such exemption would be otherwise unavailable to it). Neither the Company, nor any of its affiliates,
nor any person acting on its or their behalf, has directly or indirectly made any offers or sales of any security or solicited
any offers to buy any security under circumstances that would require registration under the Act of the issuance of the Securities
or the Brokers Warrants (as hereinafter defined). None of the Company, its predecessors or affiliates has been subject to any
order, judgment or decree of any court of competent jurisdiction temporarily, preliminarily or permanently enjoining such person
for failing to comply with Rule 503 of Regulation D or the equivalent state
securities law requirements. The Company has not, for a period of six months prior to the commencement of the offering of Securities,
sold, offered for sale or solicited any offer to buy any of its securities in a manner that would be integrated with the offer
and sale of the Securities pursuant to this Agreement, would cause the exemption from registration set forth in Rule 506 of Regulation
D and state securities laws to become unavailable with respect to the offer and sale of the Securities to this Agreement in the
United States. The Company’s common stock, par value $0.000001 per share (the
“Common Stock”) is quoted on the “Pink Sheet” maintained by OTC Markets Group Inc. (the “Principal
Market”). The Company has taken no action designed to, or likely to have the effect of, terminating the quotation of the
Common Stock on the Principal Market. The Company, on the Closing Date, will be in compliance with all of the then-applicable
requirements for continued quotation of the Common Stock on the Principal Market.

 

    	Placement Agency Agreement (PIPE)	Page 3

     

    

 

(b)          The
Subscription Documents, as prepared and contemplated by the Company, will not and do not include any untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of
the circumstances under which they were made, not misleading. To the knowledge of the Company, none of the statements, documents,
certificates or other items made, prepared or supplied by the Company with respect to the transactions contemplated hereby contains
an untrue statement of a material fact or omits to state a material fact necessary to make the statements contained therein not
misleading in light of the circumstances in which they were made. There is no fact which the Company has not disclosed in the
Subscription Documents or which is not disclosed in the filings (the “SEC Filings”, which is deemed to include the
Super 8-K) that the Company makes with the US Securities and Exchange Commission (the “SEC”) and of which the Company
is aware that materially adversely affects or that could reasonably be expected to have a material adverse effect on the (i) assets,
liabilities, results of operations, condition (financial or otherwise), business or business prospects of the Company, including
the business prospects as a result of the Merger or (ii) ability of the Company to perform its obligations under this Agreement
and the other Subscription Documents (the “Company Material Adverse Effect”). Notwithstanding anything to the contrary
herein, the Company makes no representation or warranty with respect to any estimates, projections and other forecasts and plans
(including the reasonableness of the assumptions underlying such estimates, projections and other forecasts and plans) that may
have been delivered to the Placement Agent or its respective representatives, except that such estimates, projections and other
forecasts and plans have been prepared in good faith on the basis of assumptions stated therein, which assumptions were believed
to be reasonable at the time of such preparation. Other than the Company’s SEC Filings, the Company has not distributed
and will not distribute prior to the Closing any offering material in connection with the offering and sale of the Securities,
unless such offering materials are provided to the Placement Agent prior to or simultaneously with such delivery to the offerees
of the Securities. 

 

(c)          The
Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and is
qualified and in good standing as a foreign corporation in each jurisdiction in which the nature of the business conducted by
the Company or the property owned or leased by the Company requires such qualification, except to the extent that the failure
to be so qualified or be in good standing would not have a Company Material Adverse Effect. The Company has all requisite corporate
power and authority to conduct its business as presently conducted and as proposed to be conducted (as described in the Subscription
Documents and/or the SEC Filings), has all the necessary and requisite documents and approvals from all state authorities, has
all requisite corporate power and authority to enter into and perform its obligations under this Agreement, the Subscription Agreement
substantially in the form made part of the Subscription Documents (the “Subscription Agreement”), the Registration
Rights Agreement substantially in the form made part of the Subscription Documents (the “Registration Rights Agreement”),
and the other agreements, if any, contemplated by the Offering (this Agreement, Subscription Agreement, the Registration Rights
Agreement and the other agreements contemplated hereby that the Company is required to execute and deliver are collectively referred
to herein as the “Company Transaction Documents”) and subject to necessary Board and stockholder approvals,
to issue, sell and deliver the Preferred Stock and the shares of Preferred Stock
(the “Brokers Warrant Shares”) issuable upon exercise of the Brokers Warrants (as defined below) and to make the representations
in this Agreement accurate and not misleading. Prior to the First Closing, as defined under Section 4(e), each of the Company
Transaction Documents and the Offering will have been duly authorized. This Agreement has been duly authorized, executed and delivered
and constitutes, and each of the other Company Transaction Documents, upon due execution and delivery, will constitute, valid
and binding obligations of the Company, enforceable against the Company in accordance with their respective terms (i) except as
enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws now or hereafter
in effect related to laws affecting creditors’ rights generally, including the effect of statutory and other laws regarding
fraudulent conveyances and preferential transfers, and except that no representation is made herein regarding the enforceability
of the Company’s obligations to provide indemnification and contribution remedies under the securities laws and (ii) subject
to the limitations imposed by general equitable principles (regardless of whether such enforceability is considered in a proceeding
at law or in equity).

 

    	Placement Agency Agreement (PIPE)	Page 4

     

    

 

(d)          None
of the execution and delivery of or performance by the Company under this Agreement or any of the other Company Transaction Documents
or the consummation of the transactions in this Agreement or in the Subscription Documents (including the issuance and sale of
the Securities, the issuance of the Brokers Warrants or the issuance and sale of the Brokers Warrants Shares conflicts with or
violates, or causes a default under (with our without the passage of time or the giving of notice), or will result in the creation
or imposition of, any lien, charge or other encumbrance upon any of the assets of the Company under any agreement, evidence of
indebtedness, joint venture, commitment or other instrument to which the Company is a party or by which the Company or its assets
may be bound, any statute, rule, law or governmental regulation applicable to the Company, or any term of the Article of Incorporation
as in effect on the date hereof or any closing date for the Offering (the “Articles of Incorporation”) or By-Laws
as in effect on the date hereof or any closing date for the Offering (the “By-Laws”) of the Company, or any license,
permit, judgment, decree, order, statute, rule or regulation applicable to the Company or any of its assets, except in the case
of a conflict, violation, lien, charge or other encumbrance (except with respect to the Company’s Articles of Incorporation
or By-Laws) which would not, or could not reasonably be expected to, have a Company Material Adverse Effect. No consent, approval,
authorization or other order of, or registration, qualification or filing with, any regulatory body, administrative agency, or
other governmental body is required for the execution and delivery of this Agreement by the Company and the valid issuance or
sale of the Securities, the Brokers Warrants and the Brokers Warrant Shares by the Company pursuant to this Agreement, other than
such as have been made or obtained and that remain in full force and effect, and except for the filing of a Form D or any filings
required to be made under state securities laws, which shall be timely filed by the Company.

 

(e)          The
Company’s financial statements, together with the related notes, if any, included in the Subscription Documents or the Company’s
SEC Filings, present fairly, in all material respects, the financial position of the Company as of the dates specified and the
results of operations for the periods covered thereby. Such financial statements and related notes were prepared in accordance
with United States generally accepted accounting principles applied on a consistent basis throughout the periods indicated, except
that the unaudited financial statements omit full notes, and except for normal year end adjustments. If the financials for the
Company are unaudited financial statements, it will state such clearly on the financials. During the period of engagement of the
Company’s independent certified public accountants, there have been no disagreements between the accounting firm and the
Company on any matters of accounting principles or practices, financial statement disclosure or auditing scope or procedures.
The Company has made and kept books and records and accounts which are in reasonable detail and which fairly and accurately reflect
the activities of the Company in all material respects, subject only to year-end adjustments. Except as set forth in such financial
statements or otherwise disclosed in the Company Transaction Documents, the Company’s senior management has no knowledge
of any material liabilities of any kind, whether accrued, absolute or contingent, or otherwise, and subsequent to the date of
the Company Transaction Documents and prior to the date of the First Closing, it shall not enter into any material transactions
or commitments without promptly thereafter notifying the Placement Agent and the purchasers in the Offering in writing of any
such material transaction or commitment. The other financial and statistical information with respect to the Company and any pro
forma information and related notes included in the SEC Filings present fairly the information shown therein on a basis consistent
with the financial statements of the Company included in the SEC Filings. Except as disclosed in the Subscription Documents, the
Company does not know of any facts, circumstances or conditions which could materially adversely affect its operations, earnings
or prospects that have not been fully disclosed in the financial statements appearing in the SEC Filings or other financial statements
appearing in the SEC Filings or other documents or information provided by the Company.

 

(f)          Immediately
prior to the First Closing, the shares of Preferred Stock and the Brokers Warrants Shares will have been duly authorized and,
when issued and delivered against payment therefor as provided in the Company Transaction Documents, will be validly issued, fully
paid and nonassessable. No holder of any of the shares of Preferred Stock and Brokers Warrants Shares will be subject to personal
liability solely by reason of being such a holder, and except as described in the Subscription Documents, none of the shares of
the Preferred Stock, the Brokers Warrants or the Brokers Warrants Shares will be subject to preemptive or similar rights of any
stockholder or security holder of the Company or an adjustment under the antidilution or exercise rights of any holders of any
outstanding shares of capital stock, options, warrants or other rights to acquire any securities of the Company. Immediately prior
to the First Closing, a sufficient number of authorized but unissued shares of Preferred
Stock underlying the Brokers Warrants will have been reserved for issuance upon the conversion and exercise.

 

    	Placement Agency Agreement (PIPE)	Page 5

     

    

 

(g)          Except
as described in the Subscription Documents and/or the Company’s SEC Filings and for the Brokers Warrants, and as of the
date of each Closing: (i) there will be no outstanding options, stock subscription agreements, warrants or other rights permitting
or requiring the Company or others to purchase or acquire any shares of capital stock or other equity securities of the Company
or to pay any dividend or make any other distribution in respect thereof; (ii) there will be no securities issued or outstanding
which are convertible into or exchangeable for any of the foregoing and there are no contracts, commitments or understandings,
whether or not in writing, to issue or grant any such option, warrant, right or convertible or exchangeable security; (iii) no
Securities of the Company or other securities of the Company are reserved for issuance for any purpose; (iv) there will be no
voting trusts or other contracts, commitments, understandings, arrangements or restrictions of any kind with respect to the ownership,
voting or transfer of shares of stock or other securities of the Company, including, without limitation, any preemptive rights,
rights of first refusal, proxies or similar rights, and (v) no person prior to the execution of this Agreement by the Company
holds a right to require the Company to register any securities of the Company under the Act or to participate in any such registration.
Immediately prior to the First Closing, the issued and outstanding shares of capital stock of the Company will conform in all
material respects to all statements in relation thereto contained in the Company Transaction Documents and the Company’s
SEC Filings describe all material terms and conditions thereof. All issuances by the Company of its securities have been issued
pursuant to either a current effective registration statement under the 1933 Act or an exemption from registration requirements
under the Act, and were issued in accordance with any applicable Federal and state securities laws.

 

(h)          Except
as described in the Subscription Documents and/or the Company’s SEC Filings, immediately following the First Closing, the
Company will have no subsidiaries except for PTI and will not own any equity interest and will not have made any loans or advances
to or guarantees of indebtedness to any person, corporation, partnership or other entity and will not be a party to any joint
venture. The Company’s subsidiaries are duly incorporated or organized, validly existing and in good standing under the
laws of their jurisdiction of incorporation or organization and have all requisite power and authority to carry on their business
as now conducted. Such subsidiaries are duly qualified to transact business and is in good standing in each jurisdiction in which
the failure to so qualify would have a material adverse effect on their respective business or properties. All of the outstanding
capital stock or other voting securities of such subsidiaries are owned by the Company, directly or indirectly, free and clear
of any liens, claims, or encumbrances. The conduct of business by the Company as presently and proposed to be conducted is not
subject to continuing oversight, supervision, regulation or examination by any governmental official or body of the United States,
or any other jurisdiction wherein the Company conducts or proposes to conduct such business, except as described in the Subscription
Documents and/or the Company’s SEC Filings and except as such regulation is applicable to US public companies and commercial
enterprises generally. The Company has obtained all material licenses, permits and other governmental authorizations necessary
to conduct its business as presently conducted. The Company has not received any notice of any violation of, or noncompliance
with, any federal, state, local or foreign laws, ordinances, regulations and orders (including, without limitation, those relating
to environmental protection, occupational safety and health, securities laws, equal employment opportunity, consumer protection,
credit reporting, “truth-in-lending”, and warranties and trade practices) applicable to its business, the violation
of, or noncompliance with, would have a Company Material Adverse Effect, and the Company knows of no facts or set of circumstances
which could give rise to such a notice.

 

(i)          Except
as described in the Subscription Documents and/or the Company’s SEC Filings, no default by the Company or, to the knowledge
of the Company, any other party, exists in the due performance under any material agreement to which the Company is a party or
to which any of its assets is subject (collectively, the “Company Agreements”). The Company Agreements, if any, disclosed
in the Subscription Documents and/or the Company’s SEC Filings are the only material agreements to which the Company is
bound or by which its assets are subject, are accurately described in the Subscription Documents and/or the Company’s SEC
Filings and are in full force and effect in accordance with their respective terms, subject to any applicable bankruptcy, insolvency
or other laws affecting the rights of creditors generally and to general equitable principles and the availability of specific
performance.

 

    	Placement Agency Agreement (PIPE)	Page 6

     

    

 

(j)          Subsequent
to the respective dates as of which information is given in the Subscription Documents, the Company has operated its business
in the ordinary course and, except as may otherwise be set forth in the Subscription Documents or the Company’s SEC Filings,
there has been no: (i) Company Material Adverse Effect; (ii) material transaction otherwise than in the ordinary course of business
consistent with past practice; (iii) issuance of any securities (debt or equity) or any rights to acquire any such securities
other than pursuant to equity incentive plans approved by its Board of Directors; (iv) damage, loss or destruction, whether or
not covered by insurance, with respect to any material asset or property of the Company; or (v) agreement to permit any of the
foregoing.

 

(k)          Except
as set forth in the Subscription Documents and/or the Company’s SEC Filings, there are no actions, suits, claims, hearings
or proceedings pending before any court or governmental authority or, to the knowledge of the Company, threatened, against the
Company, or involving its assets or any of its officers or directors (in their capacity as such) which, (i) if determined adversely
to the Company or such officer or director, could reasonably be expected to have a Company Material Adverse Effect or adversely
affect the transactions contemplated by this Agreement or the Company Transaction Documents (as defined in this Agreement) or
the enforceability hereof or (ii) would be required to be disclosed in the Company’s Annual Report on Form 10-K under the
requirements of Item 103 of Regulation S-K. The Company is not subject to any injunction, judgment, decree or order of any court,
regulatory body, arbitral panel, administrative agency or other government body.

 

(l)          The
Articles of Incorporation and By-laws of the Company are true, correct and complete copies of the certificate of incorporation
and bylaws of the Company, as in effect on the date hereof. Any subsequent amendments to the certificate of incorporation or bylaws
will be provided promptly to the Placement Agent and investors in the Offering. The Company is not: (i) in violation of its Articles
of Incorporation or By-Laws; (ii) in default of any contract, indenture, mortgage, deed of trust, note, loan agreement, security
agreement, lease, alliance agreement, joint venture agreement or other agreement, license, permit, consent, approval or instrument
to which the Company is a party or by which it is or may be bound or to which any of its assets may be subject, the default of
which could reasonably be expected to have a Company Material Adverse Effect; (iii) in violation of any statute, rule or regulation
applicable to the Company, the violation of which would have a Company Material Adverse Effect; or (iv) in violation of any judgment,
decree or order of any court or governmental body having jurisdiction over the Company and specifically naming the Company, which
violation or violations individually, or in the aggregate, could reasonably be expected to have a Company Material Adverse Effect.

 

(m)          Except
as disclosed in the Subscription Documents and/or the Company’s SEC Filings, as of the date of this Agreement, no current
or former stockholder, director, officer or employee of the Company, nor, to the knowledge of the Company, any affiliate of any
such person is presently, directly or indirectly through his/her affiliation with any other person or entity, a party to any loan
from the Company or any other transaction (other than as an employee) with the Company.

 

(n)          The
Company is not obligated to pay, and has not obligated the Placement Agent to pay, a finder’s or origination fee in connection
with the Offering other than to the Placement Agent under this Agreement, and hereby agrees to indemnify the Placement Agent from
any such claim made by any other person as more fully set forth in Section 8 hereof. The Company has not offered for sale or solicited
offers to purchase the Securities except for negotiations with the designated Placement Agent. 
Except as set forth in the Subscription Documents, no other person has any right to participate in any offer, sale or distribution
of the Company’s securities to which the Placement Agent’s rights, described herein, shall apply.

 

    	Placement Agency Agreement (PIPE)	Page 7

     

    

 

(o)          Until
the earlier of (i) the Termination Date or (ii) the Final Closing (as hereinafter defined), the Company will not issue any press
release, grant any interview, or otherwise communicate with the media in any manner whatsoever with respect to the Offering without
the Placement Agent’s prior written consent, which consent will not unreasonably be withheld or delayed, and subject to
any applicable laws and regulations.

 

(p)          No
representation or warranty contained in Section 2A of this Agreement contains any untrue statement of a material fact or omits
to state a material fact necessary to make the statements herein not misleading in the context of such representations and warranties.
The Placement Agent shall be entitled to rely on such representations and warranties.

 

(q)          No
consent, authorization or filing of or with any court or governmental authority is required in connection with the issuance or
the consummation of the transactions contemplated herein or in the other Company Transaction Documents, except for required filings
with the SEC and the applicable state securities commissions relating specifically to the Offering (all of which filings will
be duly made by, or on behalf of, the Company), and those which are required to be made after the First Closing (all of which
will be duly made on a timely basis).

 

(r)          Neither
the sale of the Securities by the Company nor its use of the proceeds thereof will violate the Trading with the Enemy Act, as
amended, nor any of the foreign assets control regulations of the United States Treasury Department (31 CFR, Subtitle B, Chapter
V, as amended) or any enabling legislation or executive order relating thereto. Without limiting the foregoing, the Company is
not (a) a person whose property or interests in property are blocked pursuant to Section 1 of Executive Order 13224 of September
23, 2001 Blocking Property and Prohibiting Transactions with Persons Who Commit, Threaten to Commit, or Support Terrorism (66
Fed. Reg. 49079 (2001)) or (b) a person who engages in any dealings or transactions, or be otherwise associated, with any such
person. The Company and its subsidiaries, if any, are in compliance, in all material respects, with the USA Patriot Act of 2001
(signed into law October 26, 2001). Each of the Company, its affiliates and any of their respective officers, directors, supervisors,
managers, agents, or employees, has not violated, its participation in the offering will not violate, and the Company has instituted
and maintains policies and procedures designed to ensure continued compliance with, each of the following laws: (a) anti-bribery
laws, including but not limited to, any applicable law, rule, or regulation of any locality, including but not limited to any
law, rule, or regulation promulgated to implement the OECD Convention on Combating Bribery of Foreign Public Officials in International
Business Transactions, signed December 17, 1997, including the U.S. Foreign Corrupt Practices Act of 1977, as amended, or any
other law, rule or regulation of similar purposes and scope, (b) anti-money laundering laws, including but not limited to, applicable
federal, state, international, foreign or other laws, regulations or government guidance regarding anti-money laundering, including,
without limitation, Title 18 US. Code section 1956 and 1957, the Bank Secrecy Act, and international anti-money laundering principles
or procedures by an intergovernmental group or organization, such as the Financial Action Task Force on Money Laundering, of which
the United States is a member and with which designation the United States representative to the group or organization continues
to concur, all as amended, and any Executive order, directive, or regulation pursuant to the authority of any of the foregoing,
or any orders or licenses issued thereunder or (c) laws and regulations imposing U.S. economic sanctions measures, including,
but not limited to, the International Emergency Economic Powers Act, the United Nations Participation Act and the Syria Accountability
and Lebanese Sovereignty Act, all as amended, and any Executive Order, directive, or regulation pursuant to the authority of any
of the foregoing, including the regulations of the United States Treasury Department set forth under 31 CFR, Subtitle B, Chapter
V, as amended, or any orders or licenses issued thereunder. Neither the Company nor any director, officer, agent, employee or
other person acting on behalf of the Company has, in the course of its actions for, or on behalf of, the Company (i) used any
corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses relating to political activity;
(ii) made any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds;
or (iii) made any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment to any foreign or domestic
government official or employee.

 

    	Placement Agency Agreement (PIPE)	Page 8

     

    

 

(s)          None
of Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company participating
in the Offering, any beneficial owner of 20% or more of the Company’s outstanding voting equity securities, calculated on
the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the
Company in any capacity at the time of sale (each, an “Issuer Covered Person” and, together, “Issuer Covered
Persons”) is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i)–(viii)
under the Securities Act (a “Disqualification Event”), except for a Disqualification Event covered by Rule 506(d)(2)
or (d)(3) or has been involved in any matter which would be a Disqualification Event except for the fact that it occurred before
September 23, 2013. The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification
Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished
to the Placement Agent a copy of any disclosures provided thereunder.

 

(t)          The
Company is not aware of any person (other than any Issuer Covered Person or Placement Agent Covered Person (as defined below)
that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale
of any the Securities. For purposes of this subsection Placement Agent Covered Person shall mean Katalyst Securities Inc., or
any of its directors, executive officers, general partners, managing members or other officers participating in the Offering.

 

(u)          The
Company will promptly notify the Placement Agent in writing of (A) any Disqualification Event relating to any Issuer Covered Person
and (B) any event that would, with the passage of time, become a Disqualification Event relating to any Issuer Covered Person.
The Company will notify the Agent in writing, prior to the Closing Date of (i) any Disqualification Event relating to any Issuer
Covered Person and (ii) any event that would, with the passage of time, become a Disqualification Event relating to any Issuer
Covered Person.

 

(v)         The
authorized capital stock of the Company as of the First Closing will be set forth in the Company’s SEC Filings. As of the
First Closing, the Company’s issued and outstanding capital stock will be set forth in the Company’s SEC Filings.
All issued and outstanding shares of capital stock have been duly authorized and validly issued, are fully paid and nonassessable,
were not issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities, and, except as
disclosed in the Company’s SEC Filings, have been issued and sold in compliance with the registration requirements of federal
and state securities laws or the applicable statutes of limitation have expired. Except as set forth in the Company’s SEC
Filings, there are no (i) outstanding rights (including, without limitation, preemptive rights), warrants or options to acquire,
or instruments convertible into or exchangeable for, any unissued shares of capital stock or other equity interest in the Company,
or any contract, commitment, agreement, understanding or arrangement of any kind to which the Company or its subsidiaries is a
party and relating to the issuance or sale of any capital stock or convertible or exchangeable security of the Company; or (ii)
obligations of the Company to purchase redeem or otherwise acquire any of its outstanding capital stock or any interest therein
or to pay any dividend or make any other distribution in respect thereof.

 

    	Placement Agency Agreement (PIPE)	Page 9

     

    

 

(w)          The
Company has ownership or license or legal right to use all patents, copyrights, trade secrets, know-how, trademarks, trade names,
customer lists, designs, manufacturing or other processes, computer software, systems, data compilation, research results or other
proprietary rights used in the business of the Company or its subsidiaries (collectively “Intellectual Property”).
All of such patents, registered trademarks and registered copyrights have been duly registered in, filed in or issued by the United
States Patent and Trademark Office, the United States Register of Copyrights or the corresponding offices of other jurisdictions
and have been maintained and renewed in accordance with all applicable provisions of law and administrative regulations in the
United States and all such jurisdictions. The Company believes it has taken all reasonable steps required in accordance with sound
business practice and business judgment to establish and preserve its and its subsidiaries’ ownership of all material Intellectual
Property with respect to their products and technology. To the knowledge of the Company, there is no infringement of the Intellectual
Property by any third party. To the knowledge of the Company, the present business, activities and products of the Company and
its subsidiaries do not infringe any intellectual property of any other person. There is no proceeding charging the Company or
its subsidiaries with infringement of any adversely held Intellectual Property has been filed and the Company is unaware of any
facts which are reasonably likely to form a basis for any such proceeding. There are no proceedings have been instituted or pending
or, to the knowledge of the Company, threatened, which challenge the rights of the Company or its subsidiaries to the use of the
Intellectual Property. The Intellectual Property owned by the Company and its subsidiaries, and to the knowledge of the Company,
the Intellectual Property licensed to the Company and its subsidiaries, has not been adjudged invalid or unenforceable, in whole
or in part. There is no pending or, to the knowledge of the Company, threatened proceeding by others challenging the validity
or scope of any such Intellectual Property, and the Company is unaware of any facts which are reasonably likely to form a basis
for any such claim. Each of the Company and its subsidiaries has the right to use, free and clear of material claims or rights
of other persons, all of its customer lists, designs, computer software, systems, data compilations, and other information that
are required for its products or its business as presently conducted. Neither the Company nor its subsidiaries is making unauthorized
use of any confidential information or trade secrets of any person. The activities of any of the employees on behalf of the Company
or of its subsidiaries do not violate any agreements or arrangements between such employees and third parties that are related
to confidential information or trade secrets of third parties or that restrict any such employee’s engagement in business
activity of any nature. Each former and current employee or consultant of the Company or its subsidiaries is a party to a written
contract with the Company or its subsidiaries that assigns to the Company or its subsidiaries, or has received an employee handbook
that requires an employee to assign, all rights to all inventions, improvements, discoveries and information relating to the Company
or its subsidiaries, except for any failure to so do as would not reasonably be expected to result in a Material Adverse Effect.
All licenses or other agreements under which (i) the Company or its subsidiaries employs rights in Intellectual Property, or (ii)
the Company or its subsidiaries has granted rights to others in Intellectual Property owned or licensed by the Company or its
subsidiaries are in full force and effect, and there is no default (and there exists no condition which, with the passage of time
or otherwise, would constitute a default by the Company or such subsidiary) by the Company or its subsidiaries with respect thereto.

 

(x)          The
Company has filed all necessary federal, state, local and foreign income and franchise tax returns and have paid or accrued all
taxes shown as due thereon, and except as set out in the SEC Documents, the Company has no knowledge of a tax deficiency which
has been or might be asserted or threatened against it by any taxing jurisdiction, other than any deficiency which the Company
is contesting in good faith and with respect to which adequate reserves for payment have been established.

 

(y)          The
Company maintains and will continue to maintain insurance of the types and in the amounts that the Company reasonably believes
are adequate for its business, including, but not limited to, insurance covering all real and personal property owned or leased
by the Company against theft, damage, destruction, acts of vandalism and all other risks customarily insured against by similarly
situated companies, all of which insurance is in full force and effect.

 

(z)          On each Closing Date, all stock transfer or other taxes (other than income taxes) that are required to be paid in connection
with the sale and transfer of the Securities and the Brokers Warrants will be, or will have been, fully paid or provided for by
the Company and the Company will have complied with all laws imposing such taxes.

 

(aa)         The
Company (including its subsidiaries) is not an “investment company” or an “affiliated person” of, or “promoter”
or “principal underwriter” for an investment company, within the meaning of the Investment Company Act of 1940 and
will not be deemed an “investment company” as a result of the transactions contemplated by the Offering.

 

    	Placement Agency Agreement (PIPE)	Page 10

     

    

 

(bb)         The
books, records and accounts of the Company accurately and fairly reflect, in reasonable detail, the transactions in, and dispositions
of, the assets of, and the operations of, the Company.

 

(cc)         The
Company’s statements contained in its most recent Quarterly Report on Form 10-Q for the period ended September 30, 2015
regarding its (i) disclosure controls and procedures (as such term is defined in Rule 13a-15 under the Securities Exchange Act
of 1934 (the “Exchange Act”) and (ii) internal accounting controls were and continue to be accurate. The Company is
not aware of any fraud, whether or not material, that involves management or other employees who have a significant role in the
Company’s or its subsidiaries’ internal controls. Since September 30, 2015, there have been no changes that have materially
affected, or are reasonably likely to materially affect, the Company’s or its subsidiaries’ internal control over
financial reporting, including any corrective actions with regard to significant deficiencies and material weaknesses. There are
no material off-balance sheet arrangements (as defined in Item 303 of Regulation S-K), or any other relationships with unconsolidated
entities (in which the Company or its control persons have an equity interest) that may have a material current or future effect
on the Company’s or its subsidiaries’ financial condition, revenues or expenses, changes in financial condition, results
of operations, liquidity, capital expenditures or capital resources.

 

(dd)         Neither
the Company, nor any of its affiliates, nor any person acting on its or their behalf, has engaged or will engage in any form of
general solicitation or general advertising (within the meaning of Regulation D promulgated under the Securities Act) in connection
with the offer or sale of the Securities or the Brokers Warrants.

 

(ee)         The
Company is in compliance in all material respects with any and all applicable requirements of the Sarbanes-Oxley Act of 2002 that
are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the SEC thereunder that are
effective as of the date hereof.

 

(ff)         The
Company is not a party to any collective bargaining agreement or employs any member of a union. The Company believes that its
relations with its employees are good. No executive officer of the Company, to the knowledge of the Company, is, or is now expected
to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement,
non-competition agreement, or any other contract or agreement or any restrictive covenant, and the continued employment of each
such executive officer does not subject the Company to any liability with respect to any of the foregoing matters. The Company
and its subsidiaries are in compliance with all federal, state, local and foreign laws and regulations respecting labor, employment
and employment practices and benefits, terms and conditions of employment and wages and hours, except where failure to be in compliance
would not, either individually or in the aggregate, reasonably be expected to result in a Company Material Adverse Effect.

 

(gg)         None
of the Company, its subsidiaries or any executive officer of the Company (as defined in Rule 501(f) of Regulation D under the
Securities Act) has taken and will not take any action designed to or that might reasonably be expected to cause or result in
an unlawful manipulation of the price of the Common Stock to facilitate the sale or resale of the Securities, the Brokers Warrants
or the Brokers Warrant Shares. The Company confirms that, to its knowledge, with the exception of the proposed sale of Securities,
neither it nor any other person acting on its behalf has provided any of the potential investors or their agent or counsel with
any information that constitutes or might constitute material, non-public information. The Company understands and confirms that
the potential investors shall be relying on the foregoing representations in effecting transactions in securities of the Company.

 

    	Placement Agency Agreement (PIPE)	Page 11

     

    

 

(hh)         The
Company and its board of directors have taken all necessary action, if any, in order to render inapplicable any control share
acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover
provision under the Company’s certificate of incorporation or the laws of the jurisdiction of its formation which is or
could become applicable to any potential investor as a result of the transactions contemplated by the Offering, including, without
limitation, the Company’s issuance of the Securities and any potential investor’s ownership of the Securities. The
Company has not adopted a stockholder rights plan or similar arrangement relating to accumulations of beneficial ownership of
its capital stock or a change in control of the Company.

 

(ii)         The
Company acknowledges that the Placement Agent, its sub agents, legal counsel to the Company and/or their respective affiliates,
principals, representatives or employees may now or hereafter own shares of the Company.

 

B.            Representations,
Warranties and Covenants of Katalyst. Katalyst hereby represents and warrants to the Company that the following representations
and warranties are true and correct as of the date of this Agreement:

 

(a)          Katalyst
represents that neither it, nor to its knowledge any of its Sub- Agents or any of its or their respective directors, executive
officers, general partners, managing members or other officers participating in the Offering (each, a “Katalyst Covered
Person” and, together, “Katalyst Covered Persons”), is subject to any of the “Bad Actor” disqualifications
described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a “Disqualification Event”) or has been
involved in any matter which would be a Disqualification Event except for the fact that it occurred before September 23, 2013.

 

(b)          Katalyst
will notify the Company promptly in writing of any Disqualification Event relating to any Katalyst Covered Person not previously
disclosed to the Company in accordance with the prior section.

 

3.             Placement
Agent Compensation.

 

(a)           In
connection with the Offering, the Company will pay a cash fee (the “Broker Cash Fee”) to the Placement Agent at each
Closing equal to 10% of each Closing’s gross proceeds from any sale of Securities in the Offering to investors introduced
to the Company by the Placement Agent during the Term. The Placement Agent shall not be entitled to receive a Broker Cash Fee
for gross proceeds raised in the Offering from other investors, including, but not limited to, institutional investors, investors
included on the PTI investor list attached hereto as Exhibit 1 (which list may
be updated in writing from time to time during the Term with additional investors), investors converting debt into equity,
unless negotiated by the Placement Agent and the Company and in writing. The Broker Cash Fee shall be paid to the Placement Agent
in cash by wire transfer from the escrow account established for the Offering, and as a condition to closing, simultaneous with
the distribution of funds to the Company.

 

(b)           Also,
at each Closing, the Company will deliver to the Placement (or its designees), warrants exercisable for a period of five (5) years
in the form of Attachment I to purchase shares of the Company’s Preferred
Stock equal, in the aggregate, to 10% of the number of shares of Preferred Stock
sold in the Offering to the investors introduced to the Company by the Placement Agent, which warrants shall have an exercise
price equal to $1.25 per share of Preferred Stock (“Brokers Warrants”).
The Placement Agent shall not be entitled to receive the Broker Warrants for gross proceeds raised in the Offering from other
investors, including, but not limited to, institutional investors, investors included
on the PTI investor list attached hereto (which list may be updated in writing
from time to time during the Term with additional investors), investors converting debt into equity, unless negotiated
by the Placement Agent and the Company and put in writing. To the extent permitted by applicable laws, all warrants shall permit
unencumbered transfer to the Placement Agent’s employees and affiliates and the warrants may be issued directly to the Placement
Agent’s employees and affiliates at the Placement Agent’s request. The Broker Cash Fee and the Broker Warrants are
sometimes referred to collectively as the “Brokers Fees”).

 

(c)           To
the extent there is more than one Closing, payment of the proportional amount of the Broker Cash Fees will be made out of the
gross proceeds from any sale of Securities sold at each Closing and the Company will issue to the Placement Agent the corresponding
number of Brokers Warrants. All cash compensation and warrants under this Agreement shall be paid directly by the Company to and
in the name provided to the Company by the Placement Agent.

 

    	Placement Agency Agreement (PIPE)	Page 12

     

    

 

4.             Subscription
and Closing Procedures.

 

(a)           The
Company shall cause to be delivered to the Placement Agent copies of the Subscription Documents and has consented, and hereby
consents, to the use of such copies for the purposes permitted by the Act and applicable securities laws and in accordance with
the terms and conditions of this Agreement, and hereby authorizes the Placement Agent and its agents and employees to use the
Subscription Documents in connection with the sale of the Securities until the earlier of (i) the Termination Date or (ii) the
Final Closing, and no person or entity is or will be authorized to give any information or make any representations other than
those contained in the Subscription Documents or to use any offering materials other than those contained in the Subscription
Documents in connection with the sale of the Securities, unless the Company first provides the Placement Agent with notification
of such information, representations or offering materials.

 

(b)           The
Company shall make available to the Placement Agent and its representatives such information, including, but not limited to, financial
information, and other information regarding the Company (the “Information”), as may be reasonably requested in making
a reasonable investigation of the Company and its affairs. The Company shall provide access to the officers, directors, employees,
independent accountants, legal counsel and other advisors and consultants of the Company as shall be reasonably requested by the
Placement Agent. The Company recognizes and agrees that the Placement Agent (i) will use and rely primarily on the Information
and generally available information from recognized public sources in performing the services contemplated by this Agreement without
independently verifying the Information or such other information, (ii) does not assume responsibility for the accuracy of the
Information or such other information, and (iii) will not make an appraisal of any assets or liabilities owned or controlled by
the Company or its market competitors.

 

(c)           Each
prospective purchaser will be required to complete and execute the Subscription Documents, Anti-Money Laundering Form, Accredited
Investor Certification and other documents which will be forwarded or delivered to the Placement Agent at the Placement Agent’s
offices at the address set forth in Section 12 hereof or to an address identified in the Subscription Documents.

 

(d)           Simultaneously
with the delivery to the Placement Agent of the Subscription Documents, the subscriber’s check or other good funds will
be forwarded directly by the subscriber to the escrow agent and deposited into a non interest bearing escrow account (the “Escrow
Account”) established for such purpose (the “Escrow Agent”). All such funds for subscriptions will be held in
the Escrow Account pursuant to the terms of an escrow agreement among the Company, the Placement Agent and the Escrow Agent.
The Company will pay all fees related to the establishment and maintenance of the Escrow Account. Subject to the receipt of
subscriptions for the amount for Closing, the Company will either accept or reject, for any or no reason, the Subscription Documents
in a timely fashion and at each Closing will countersign the Subscription Documents and provide duplicate copies of such documents
to the Placement Agent for distribution to the subscribers. The Company will give notice to the Placement Agent of its acceptance
of each subscription. The Company, or the Placement Agent on the Company’s behalf, will promptly return to subscribers incomplete,
improperly completed, improperly executed and rejected subscriptions and give written notice thereof to the Placement Agent upon
such return.

 

    	Placement Agency Agreement (PIPE)	Page 13

     

    

 

(e)           If
subscriptions for at least the Minimum Offering Amount for Closing have been accepted prior to the Termination Date, the funds
therefor have been collected by the Escrow Agent and all of the conditions set forth elsewhere in this Agreement are fulfilled,
a closing shall be held promptly with respect to the Securities sold (the “First Closing”). Thereafter, the remaining
Securities will continue to be offered and sold until the earlier of the Termination Date or the date that additional subscription
amounts up to the Maximum Offering amount have been collected by the Escrow Agent. Additional Closings (each a “Closing”,
collectively “Closings”) may from time to time be conducted at times mutually agreed to between the Company and the
Placement Agent with respect to additional Securities sold, with the final closing (“Final Closing”) to occur within
10 days after the earlier of the Termination Date and the date on which the Maximum Amount has been subscribed for. Delivery of
payment for the accepted subscriptions for the Securities from the funds held in the Escrow Account will be made at each Closing
at the Placement Agent’s office against delivery of the Securities by the Company at the address set forth in Section 12
hereof (or at such other place as may be mutually agreed upon between the Company and the Placement Agent), net of amounts agreed
upon by the parties herein, including, the Blue Sky counsel as of such Closing. The Preferred Stock will be issued and registered
electronically with the stock transfer agent after each Closing. Upon conversion of the Preferred Stock, executed certificates
for the Common Stock will be forwarded to the subscriber directly by the stock transfer agent within ten (10) days following the
conversion of the Preferred Stock. Executed certificates for the Brokers Warrants will be issued in such authorized denominations
and registered in such names as the Placement Agent may request on or before the date of each Closing (“Closing Date”).
At each Closing, the Company will (i) deliver irrevocable issuance instruction to its stock transfer agent for the electronic
registration of the Preferred Stock being sold, and (ii) issue and deliver the applicable Brokers Warrants.

 

(f)            If
Subscription Documents for the Minimum Offering Amount for Closing have not been received and accepted by the Company on or before
the Termination Date for any reason, the Offering will be terminated, no Securities will be sold, and the Escrow Agent will, at
the request of the Placement Agent, cause all monies received from subscribers for the Securities to be promptly returned to such
subscribers without interest, penalty, expense or deduction.

 

5.             Further
Covenants. The Company hereby covenants and agrees that:

 

(a)           Except
upon prior written notice to the Placement Agent, the Company shall not, at any time prior to the Final Closing, knowingly take
any action which would cause any of the representations and warranties made by it in this Agreement not to be complete and correct
in all material respects on and as of the date of each Closing with the same force and effect as if such representations and warranties
had been made on and as of each such date (except to the extent any representation or warranty relates to an earlier date).

 

(b)           If,
at any time prior to the Final Closing, any event shall occur that causes a Company Material Adverse Effect which as a result
it becomes necessary to amend or supplement the Subscription Documents so that the representations and warranties herein remain
true and correct in all material respects, or in case it shall be necessary to amend or supplement the Subscription Documents
to comply with Regulation D or any other applicable securities laws or regulations, the Company will promptly notify the Placement
Agent and shall, at its sole cost, prepare and furnish to the Placement Agent copies of appropriate amendments and/or supplements
in such quantities as the Placement Agent may reasonably request. The Company will not at any time before the Final Closing prepare
or use any amendment or supplement to the Subscription Documents of which the Placement Agent will not previously have been advised
and furnished with a copy, or which is not in compliance in all material respects with the Act and other applicable securities
laws. As soon as the Company is advised thereof, the Company will advise the Placement Agent and its counsel, and confirm the
advice in writing, of any order preventing or suspending the use of the Subscription Documents, or the suspension of any exemption
for such qualification or registration thereof for offering in any jurisdiction, or of the institution or threatened institution
of any proceedings for any of such purposes, and the Company will use their best efforts to prevent the issuance of any such order
and, if issued, to obtain as soon as reasonably possible the lifting thereof.

 

    	Placement Agency Agreement (PIPE)	Page 14

     

    

 

(c)           The
Company shall comply with the Act, the Exchange Act, the rules and regulations thereunder, all applicable state securities laws
and the rules and regulations thereunder in the states in which the Company’s Blue Sky counsel has advised the Placement
Agent and/or the Company that the Securities are qualified or registered for sale or exempt from such qualification or registration,
so as to permit the continuance of the sales of the Securities, and will file or cause to be filed with the SEC, and shall promptly
thereafter forward or cause to be forwarded to the Placement Agent, any and all reports on Form D as are required. The Company
will pay the attorney’s fee and out of pocket expenses related to the filings for registrations of sale or exemption from
such qualifications with any state securities commissions and any other regulatory agencies. Such fees will be paid at the time
of invoicing, or at the time of Closing, if known, and if not yet invoiced, funds will remain in escrow to cover the estimated
invoice. The Company will pay the invoice or authorize release of the funds from escrow within five (5) days of receipt of invoice.

 

(d)           The
Company, at its own cost and expense, shall use best efforts to qualify the Securities for sale under the securities laws of such
jurisdictions in the United States as may be mutually agreed to by the Company and the Placement Agent, and the Company will make
or cause to be made such applications and furnish information as may be required for such purposes, provided that the Company
will not be required to qualify as a foreign corporation in any jurisdiction or execute a general consent to service of process.
The Company will, from time to time, prepare and file such statements and reports as are or may be required to continue such qualifications
in effect for so long a period as the Placement Agent may reasonably request with respect to the Offering.

 

(e)           The
Company shall place a legend on the certificates representing the shares of the Preferred Stock and the Brokers Warrants that
the securities evidenced thereby have not been registered under the Act or applicable state securities laws, setting forth or
referring to the applicable restrictions on transferability and sale of such securities under the Act and applicable state laws.

 

(f)           The
Company shall apply the net proceeds from the sale of the Securities for the purposes set forth in the Subscription Documents.
Except as set forth in the Subscription Documents, the Company shall not use any of the net proceeds of the Offering to repay
indebtedness to officers (other than accrued salaries incurred in the ordinary course of business), directors or stockholders
of the Company without the prior written consent of the Placement Agent. 

 

(g)           During
the Offering Period, the Company shall afford each prospective purchaser of Securities the opportunity to ask questions of and
receive answers from an officer of the Company concerning the terms and conditions of the Offering and the opportunity to obtain
such other additional information necessary to verify the accuracy of the Subscription Documents to the extent the Company possesses
such information or can acquire it without unreasonable expense.

 

(h)           Except
with the prior written consent of the Placement Agent, the Company shall not, at any time prior to the earlier of the Final Closing
or the Termination Date, except as contemplated by the Subscription Documents (i) engage in or commit to engage in any transaction
other than the Merger outside the ordinary course of business as described in the Subscription Documents, (ii) issue, agree to
issue or set aside for issuance any securities (debt or equity) or any rights to acquire any such securities, (iii) incur, outside
the ordinary course of business, any material indebtedness, (iv) dispose of any material assets, (v) make any material acquisition
or (vi) change its business or operations in any material respect.

 

    	Placement Agency Agreement (PIPE)	Page 15

     

    

 

(i)            Whether
or not the transactions contemplated hereby are consummated, or this Agreement is terminated, the Company shall pay all reasonable
expenses incurred in connection with the preparation and printing of all necessary offering documents and instruments related
to the Offering and the issuance of the Preferred Stock and the Brokers Warrants and will also pay for the Company’s expenses
for accounting fees, legal fees, printing costs, and other costs involved with the Offering. The Company will provide at its own
expense such quantities of the Subscription Documents and other documents and instruments relating to the Offering as the Placement
Agent may reasonably request. The Company will pay at its own expense in connection with the creation, authorization, issuance,
transfer and delivery of the Securities, including, without limitation, fees and expenses of any transfer agent or registrar;
the fees and expenses of the Escrow Agent; all fees and expenses of legal, accounting and other advisers to the Company; the registration
or qualification of the Securities for offer and sale under the securities or Blue Sky laws of such jurisdictions, payable within
five (5) days of being invoiced. The Company will pay all such amounts, unless previously paid, at the First Closing, or, if there
is no Closing, within ten (10) days after written request therefor following the Termination Date. In addition to any fees payable
to the Placement Agent hereunder, contingent upon the occurrence of the First Closing,
the Company hereby agrees to pay from the escrow proceeds at the First Closing, the Placement Agent’s legal counsel fees
and legal out of pocket expenses in the amount of Fifteen Thousand Dollars ($15,000). For
the avoidance of doubt, any expenses in excess of such $15,000 (other than expenses covered by Sections 8 and 9 of this Agreement)
shall be solely the responsibility of the Placement Agent. Without limiting the generality of the foregoing, the Placement
Agent will be responsible for its own out-of-pocket expenses in performing the services described herein unless agreed in writing
to be paid by the Company or PTI. This reimbursement obligation is in addition to the reimbursement of fees and expenses relating
to attendance by the Placement Agent at proceedings or to indemnification and contribution as contemplated elsewhere in this agreement.
In the event either Placement Agent’s personnel must attend or participate in judicial or other proceedings to which we
are not a party relating to the subject matter of this agreement, the Company shall pay such Placement Agent an additional per
diem payment, per person, at our customary rates, together with reimbursement of all out-of-pocket expenses and disbursements,
including reasonable attorneys’ fees and disbursements incurred by it in respect of its preparation for and participation
in such proceedings.

 

(j)            On
each Closing Date, the Company permits the Placement Agent to rely on any representations and warranties made by the Company to
the investors and will cause its counsel to permit the Placement Agent to rely upon any opinion furnished to the investors in
the Private Placement.

 

(k)            The
Company will comply with all of its obligations and covenants set forth in its agreements with the investors in the Offering.
If not filed on EDGAR, the Company will promptly deliver to the Placement Agent and their counsel copies of any and all filings
with the SEC and each amendment or supplement thereto, as well as all prospectuses and free writing prospectuses, prior to the
closing of the Offering and six months thereafter. The Placement Agent is authorized on behalf of the Company to use and distribute
copies of any Subscription Documents, including Company’s SEC Filings in connection with the sale of the Securities as,
and to the extent, permitted by federal and applicable state securities laws. The Company acknowledges and agrees that the Placement
Agent will be relying, without assuming responsibility for independent verification, on the accuracy and completeness of all financial
and other information that is and will be furnished to them by the Company and the Company will be liable for any material misstatements
or omissions contained therein.

 

6.            Conditions
of Placement Agent’s Obligations. The obligations of the Placement Agent hereunder to affect a Closing are subject
to the fulfillment, at or before each Closing, of the following additional conditions:

 

(a)           Each
of the representations and warranties made by the Company (which shall take into account that the Merger has been consummated
such that all representations and warranties referring to the Company shall relate to the Company and its subsidiaries following
completion of the Merger) shall be true and correct on each Closing Date.

 

(b)           The
Company shall have performed and complied in all material respects with all agreements, covenants and conditions required to be
performed, and complied with by it at or before the Closing.

 

(c)           The
Subscription Documents do not, and as of the date of any amendment or supplement thereto will not, include any untrue statement
of a material fact or omit to state any material fact necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading.

 

    	Placement Agency Agreement (PIPE)	Page 16

     

    

 

(d)           No
order suspending the use of the Subscription Documents or enjoining the Offering or sale of the Securities shall have been issued,
and no proceedings for that purpose or a similar purpose shall have been initiated or pending, or, to the best of the Company’s
knowledge, be contemplated or threatened.

 

(e)           No
holder of any of the Securities from the Offering will be subject to personal liability solely by reason of being such a holder,
and except as described in the Subscription Documents, none of the Company’s shares of Preferred
Stock and Brokers Warrant Shares will be subject to preemptive or similar rights of any stockholder or security holder
of the Company, or an adjustment under the antidilution or exercise rights of any holders of any outstanding shares of capital
stock, membership units, options, warrants or other rights to acquire any securities of the Company. 

 

(f)            There
shall have been no material adverse change nor development involving a prospective change in the financial condition, operations
or projects of the Company, except where such change would not have a Company Material Adverse Effect on the business activities,
financial or otherwise, results of operations or prospects of the Company, taken individually or in the aggregate.

 

(g)           The
Placement Agent shall have received a certificate of the Chief Executive Officer of the Company, dated as of the Closing Date,
certifying, as to the fulfillment of the conditions set forth in subparagraphs (a), (b), (c), (d), (e) and (f) above.

 

(h)           The
Company shall have delivered to the Placement Agent: (i) a good standing certificate dated as of a date within 10 days prior to
the date of the First Closing from the secretary of state of its jurisdiction of incorporation and (ii) resolutions of the Company’s
Board of Directors approving this Agreement and the transactions and agreements contemplated by this Agreement, and the Subscription
Documents, all as certified by the Chief Executive Officer of the Company.

 

(i)            At
each Closing, the Company shall have (i) paid to the Placement Agent the Broker Cash Fee in respect of all Securities sold at
such Closing, (ii) executed and delivered to the Placement Agent the Brokers Warrants in respect of all Securities sold at such
Closing, and (iii) paid all fees, costs and expenses as set forth in Section 5 hereof.

 

(j)            There
shall have been delivered to the Placement Agent a signed opinion of counsel to the Company dated as of the Closing Date.

 

(k)            Prior
to the closing of the Offering, the Company shall have engaged American Stock Transfer as its transfer agent for purposes of handling
the transfers of its capital stock and other securities

 

(l)            All
proceedings taken at or prior to the Closing in connection with the authorization, issuance and sale of the Preferred Stock and
the Brokers Warrants will be reasonably satisfactory in form and substance to the Placement Agent and its counsel, and such counsel
shall have been furnished with all such documents, certificates and opinions as it may reasonably request upon reasonable prior
notice in connection with the transactions contemplated hereby.

 

(m)          The
Company agrees and understands that this Agreement in no way constitutes a guarantee that the Offering will be successful. The
Company acknowledges that the Company is ultimately responsible for the successful completion of a transaction.

 

7.             Conditions
of the Company’s Obligations. The obligations of the
Company hereunder are subject to the satisfaction of each of the following conditions:

 

(a)           The
satisfaction or waiver of all conditions to Closing as set forth herein.

 

(b)           As
of each Closing, each of the representations and warranties made by Placement Agent herein being true and correct as of the Closing
Date for such Closing.

 

(c)           At
each Closing, the Company shall have received the proceeds from the sale of the Securities that are part of such Closing less
applicable Broker Fees and other deductions contemplated by this Agreement.

 

    	Placement Agency Agreement (PIPE)	Page 17

     

    

 

(d)          At
each Closing, the Company shall have received a copy of Subscription Documents signed by investors delivered by the Placement
Agent.

 

7A.          Mutual
Condition. The obligations of the Placement Agent and the Company hereunder are subject to the execution by each investor
of a Subscription Agreement in form and substance acceptable to the Placement Agent and the Company and deposit by such investor
with the escrow agent of all funds required to be so deposited by such investor.

 

8.             Indemnification.

 

(a)          The
Company will: (i) indemnify and hold harmless the Placement Agent, and its agents and their respective officers, directors, employees,
agents, selected dealers and each person, if any, who controls the Placement Agent within the meaning of the Act and such agents
(each a “Placement Agent Indemnitee”
or a “Placement Agent Party”) against, and pay or reimburse each Placement
Agent Indemnitee for, any and all losses, claims, damages, liabilities or expenses whatsoever (or actions or proceedings
or investigations in respect thereof (collectively, “Proceedings”), joint or several (which will, for all purposes
of this Agreement, include, but not be limited to, all reasonable costs of defense and investigation and all reasonable attorneys’
fees, including appeals), to which any Placement Agent Indemnitee may become
subject (a) under the Act or otherwise, in connection with the offer and sale of the Securities and (b) as a result of the breach
of any representation, warranty or covenant made by the Company herein or the failure of the Company to perform its obligations
under the Agreement, regardless of whether such losses, claims, damages, liabilities or expenses shall result from any claim by
any Indemnitee or by any third party; and (ii) reimburse each Placement Agent
Indemnitee for any legal or other expenses reasonably incurred in connection with investigating or defending against any such
loss, claim, action, proceeding or investigation; provided, however, that
the Company will not be liable in any such case to the extent that any such claim, damage or liability is finally
judicially determined to have resulted primarily from (A) an untrue statement
or alleged untrue statement of a material fact made in the Subscription Documents, or an omission or alleged omission to state
therein a material fact required to be stated therein or necessary to make the statements therein not misleading, made solely
in reliance upon and in conformity with written information furnished to the Company by the Placement Agent specifically for use
in the Subscription Documents, (B) any violations by the Placement Agent of the Act, state securities laws or any rules or regulations
of FINRA, which does not result from a violation thereof by the Company or any of its respective affiliates or (C) the Placement
Agent’s willful misconduct or gross negligence. In addition to
the foregoing agreement to indemnify and reimburse, the Company will indemnify and hold harmless each
Placement Agent Indemnitee against any and all losses, claims, damages, liabilities or expenses whatsoever (or actions
or proceedings or investigations in respect thereof), joint or several (which shall, for all purposes of this Agreement, include,
but not be limited to, all reasonable costs of defense and investigation and all reasonable attorneys’ fees, including appeals)
to which any Placement Agent Indemnitee may become subject insofar as such costs,
expenses, losses, claims, damages or liabilities arise out of or are based upon the claim of any person or entity that he or it
is entitled to broker’s or finder’s fees from any Placement Agent
Indemnitee in connection with the Offering as a result of the Company obligating itself or any Indemnitee to pay such a fee, other
than fees due to the Placement Agent, its dealers, sub-agents or finders. The foregoing indemnity agreements will be in addition
to any liability the Company may otherwise have. The Placement Agent Indemnitees
are intended third party beneficiaries of this provision.

 

    	Placement Agency Agreement (PIPE)	Page 18

     

    

 

(b)            The
Placement Agent will: (i) indemnify and hold harmless the Company, and its agents and their respective officers, directors, employees,
agents, selected dealers and each person, if any, who controls the Company within the meaning of the Act and such agents (each
a “Company Indemnitee” or a “Company Party”) against, and pay or reimburse each Company Indemnitee for,
any and all losses, claims, damages, liabilities or expenses whatsoever (or Proceedings, joint or several (which will, for all
purposes of this Agreement, include, but not be limited to, all reasonable costs of defense and investigation and all reasonable
attorneys’ fees, including appeals), to which any Company Indemnitee may become subject (a) under the Act or otherwise,
in connection with the offer and sale of the Securities and (b) which results from (x) any untrue statement or alleged untrue
statement of any material fact contained in the Subscription Documents made in reliance upon and in conformity with information
contained in the Subscription Documents relating to the Placement Agent, or an omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements therein not misleading, in either case, if made
or omitted in reliance upon and in conformity with written information furnished to the Company by the Placement Agent, specifically
for use in the preparation thereof or (y) any violations by the Placement Agent of the Act or state securities laws which does
not result from a violation thereof by the Company Indemnitees or any of their respective affiliates, and (ii) reimburse each
Company Indemnitee for any legal or other expenses reasonably incurred in connection with investigating or defending against any
such loss, claim, action, proceeding or investigation; provided, however, in no event (except in the event of gross negligence
or willful misconduct by the Placement Agent to the extent and only to the extent if found in a final judgment by a court of competent
jurisdiction) shall the Placement Agent’s indemnification obligation hereunder exceed the amount of Broker Cash Fees actually
received by the Placement Agent. 

 

(c)            Promptly
after receipt by an indemnified party under this Section 8 of notice of the commencement of any action, claim, proceeding or investigation
(the “Action”), such indemnified party, if a claim in respect thereof is to be made against the indemnifying party
under this Section 8, will notify the indemnifying party of the commencement thereof, but the omission to so notify the indemnifying
party will not relieve it from any liability that it may have to any indemnified party under this Section 8 unless the indemnifying
party has been substantially prejudiced by such omission. The indemnifying party will be entitled to participate in and, to the
extent that it may wish, jointly with any other indemnifying party, to assume the defense thereof subject to the provisions herein
stated, with counsel reasonably satisfactory to such indemnified party. The indemnified party will have the right to employ separate
counsel in any such Action and to participate in the defense thereof, but the fees and expenses of such counsel will not be at
the expense of the indemnifying party if the indemnifying party has assumed the defense of the Action with counsel reasonably
satisfactory to the indemnified party, provided, however, that if the indemnified party shall be requested by the indemnifying
party to participate in the defense thereof or shall have concluded in good faith and specifically notified the indemnifying party
either that there may be specific defenses available to it that are different from or additional to those available to the indemnifying
party or that such Action involves or could have a material adverse effect upon it with respect to matters beyond the scope of
the indemnity agreements contained in this Agreement, then the counsel representing it, to the extent made necessary by such defenses,
shall have the right to direct such defenses of such Action on its behalf and in such case the reasonable fees and expenses of
such counsel in connection with any such participation or defenses shall be paid by the indemnifying party. No settlement of any
Action against an indemnified party will be made without the consent of the indemnifying party and the indemnified party, which
consent shall not be unreasonably withheld or delayed in light of all factors of importance to such party, and no indemnifying
party shall be liable to indemnify any person for any settlement of any such claim effected without such indemnifying party’s
consent. Notwithstanding the immediately preceding sentence, if at any time an indemnified party requests the indemnifying party
to reimburse the indemnified party for legal or other expenses in connection with investigating, responding to or defending any
Proceedings as contemplated by this indemnity agreement, the indemnifying party will be liable for any settlement of any Proceedings
effected without its written consent if (i) the proposed settlement is entered into more than 30 days after receipt by the indemnifying
party of the request for reimbursement, (ii) the indemnifying party has not reimbursed the indemnified party within 30 days of
such request for reimbursement, (iii) the indemnified party delivered written notice to the indemnifying party of its intention
to settle and the failure to pay within such 30 day period, and (iv) the indemnifying party does not, within 15 days of receipt
of the notice of the intention to settle and failure to pay, reimburse the indemnified party for such legal or other expenses
and object to the indemnified party’s seeking to settle such Proceedings.

 

    	Placement Agency Agreement (PIPE)	Page 19

     

    

 

9.             Contribution.
To provide for just and equitable contribution, if: (i) an indemnified party makes a claim for indemnification pursuant to Section
8 hereof and it is finally determined, by a judgment, order or decree not subject to further appeal that such claims for indemnification
may not be enforced, even though this Agreement expressly provides for indemnification in such case; or (ii) any indemnified or
indemnifying party seeks contribution under the Act, the Exchange Act, or otherwise, then each indemnifying party shall contribute
to such amount paid or payable by such indemnified party in such proportion as is appropriate to reflect not only such relative
benefits but also the relative fault of the Company on the one hand and the Placement Agent on the other in connection with the
statements or omissions which resulted in such losses, claims, damages, liabilities or expenses (or actions in respect thereof),
as well as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and the
Placement Agent on the other shall be deemed to be in the same proportion as the total net proceeds from the Offering (before
deducting expenses) received by the Company bear to the total Brokers’ Fees received by the Placement Agent. The relative
fault, in the case of an untrue statement, alleged untrue statement, omission or alleged omission will be determined by, among
other things, whether such statement, alleged statement, omission or alleged omission relates to information supplied by the Company
or by the Placement Agent, and the parties’ relative intent, knowledge, access to information and opportunity to correct
or prevent such statement, alleged statement, omission or alleged omission. The Company and the Placement Agent agree that it
would be unjust and inequitable if the respective obligations of the Company and the Placement Agent for contribution were determined
by pro rata allocation of the aggregate losses, liabilities, claims, damages and expenses or by any other method or allocation
that does not reflect the equitable considerations referred to in this Section 9. No person guilty of a fraudulent misrepresentation
(within the meaning of Section 10(f) of the Act) will be entitled to contribution from any person who is not guilty of such fraudulent
misrepresentation. For purposes of this Section 9, each person, if any, who controls the Placement Agent within the meaning of
the Act will have the same rights to contribution as the Placement Agent, and each person, if any, who controls the Company within
the meaning of the Act will have the same rights to contribution as the Company, subject in each case to the provisions of this
Section 9. Anything in this Section 9 to the contrary notwithstanding, no party will be liable for contribution with respect to
the settlement of any claim or action effected without its written consent. This Section 9 is intended to supersede, to the extent
permitted by law, any right to contribution under the Act, the Exchange Act or otherwise available.

 

10.           Termination.

 

(a)           The
Offering may be terminated by the Placement Agent at any time prior to the expiration of the Offering Period in the event that:
(i) any of the representations, warranties or covenants of the Company contained herein or in the Subscription Documents shall
prove to have been false or misleading in any material respect when actually made; (ii) the Company shall have failed to perform
any of its material obligations hereunder or under any other Company Transaction Document or any other transaction document; (iii)
there shall occur any event, within the control of the Company that is reasonably likely to materially and adversely affect the
transactions contemplated hereunder or the ability of the Company to perform hereunder; or (iv) the Placement Agent determines
that it is reasonably likely that any of the conditions to Closing to be fulfilled by the Company set forth herein will not, or
cannot, be satisfied.

 

(b)           This Offering may be terminated by the Company at any time prior to the Termination Date in the event that (i) the
Placement Agent shall have failed to perform any of its material obligations hereunder or (ii) on account of the Placement
Agent’s fraud, illegal or willful misconduct or gross negligence. In the event of any termination by the Company, the
Placement Agent shall be entitled to receive, on the Termination Date, all unpaid Broker Fees earned or accrued through the
Termination Date and reimbursement of all expenses as provided for in this Agreement, but shall be entitled to no other
amounts whatsoever except as may be due under any indemnity or contribution obligation for provided herein, at law or
otherwise. On such Termination Date, the Company shall pay all such unpaid costs and expenses incurred by the Placement Agent
in connection with the Offering, Placement Agent counsel fee provided above and all unpaid Blue Sky Fees and other expenses
set forth in Section 5(i) hereof.

 

    	Placement Agency Agreement (PIPE)	Page 20

     

    

 

(c)           This
Offering may be terminated upon mutual agreement of the Company and the Placement Agent at any time prior to the expiration of
the Offering Period.

 

(d)           Except
as otherwise provided above, before any termination by the Placement Agent under Section 10(a) or by the Company under Section
10(b) shall become effective, the terminating party shall give ten (10) day prior written notice to the other party of its intention
to terminate the Offering (the “Termination Notice”). The Termination Notice shall specify the grounds for the proposed
termination. If the specified grounds for termination, or their resulting adverse effect on the transactions contemplated hereby,
are curable, then the other party shall have five (5) days from the Termination Notice within which to remove such grounds or
to eliminate all of their material adverse effects on the transactions contemplated hereby; otherwise, the Offering shall terminate.

 

(e)           Upon
any termination pursuant to this Section 10, the Placement Agent and the Company will instruct the Escrow Agent to cause all monies
received with respect to the subscriptions for Securities not accepted by the Company to be promptly returned to such subscribers
without interest, penalty or deduction.

 

11.          Survival.

 

(a)           The
obligations of the parties to pay any costs and expenses hereunder and to provide indemnification and contribution as provided
herein shall survive any termination hereunder. In addition, the provisions of Sections 3, and 8 through 22 shall survive the
sale of the Securities or any termination of the Offering hereunder.

 

(b)           The
respective indemnities, covenants, representations, warranties and other statements of the Company and the Placement Agent set
forth in or made pursuant to this Agreement will remain in full force and effect, regardless of any investigation made by or on
behalf of, and regardless of any access to information by the Company or the Placement Agent, or any of their officers or directors
or any controlling person thereof, and will survive the sale of the Securities or any termination of the Offering hereunder.

 

12.          Notices.
All notice and other communications hereunder will be in writing and shall be deemed effectively given to a party by (a) personal
delivery; (b) upon deposit with the United States Post Office, by certified mail, return receipt requested, first-class mail,
postage prepaid; (c) delivered by hand or by messenger or overnight courier, addressee signature required, to the addresses below
or at such other address and/or to such other persons as shall have been furnished by the parties:

 

	If to the Company
    (on or prior to	 
	the
    First Closing):	Atrinsic, Inc.
	 	Mr. Edward Gildea
	 	65 Atlantic Avenue
	 	Boston, MA 02110
	 	 
	With
    a copy to:	Sanders Ortoli Vaughn-Flam Rosentadt
	(which
    shall not constitute notice)	501 Madison Avenue, 14th
    Floor
	 	New York, NY 10022
	 	Attention:  Tim Dockery,
    Esq.
	 	 
	If
    to the Company (subsequent to	 
	the
    First Closing):	Atrinsic, Inc.
	 	Mr. Robert Ziroyan
	 	149 Fifth Avenue, Suite 500
	 	New York, NY 10010

 

    	Placement Agency Agreement (PIPE)	Page 21

     

    

 

	With
    a copy to:	Meister
    Seelig & Fein LLP
	(which
    shall not constitute notice)	125
    Park Avenue, 7th Floor
	 	New
    York, NY 10017
	 	Attention:  Kenneth
    S. Goodwin, Esq.
	 	 
	If
    to Katalyst Securities LLC.	Katalyst
    Securities LLC
	 	15
    Maiden Lane, Room 601
	 	New
    York, NY 10038
	 	Attention:  Paul
    Ehrenstein
	 	President
	 	 
	With
    a copy to:	Barbara
    J. Glenns, Esq.
	(which
    shall not constitute notice)	Law
    Office of Barbara J. Glenns, Esq.
	 	30
    Waterside Plaza, Suite 25G
	 	New
    York, NY 10010

 

13.          Governing
Law, Jurisdiction. This Agreement shall be deemed to have been made and delivered in New York City and shall be governed
as to validity, interpretation, construction, effect and in all other respects by the internal laws of the State of New York without
regard to principles of conflicts of law thereof.

 

THE
PARTIES HERETO AGREE TO SUBMIT ALL CONTROVERSIES TO THE EXCLUSIVE JURISDICTION OF FINRA ARBITRATION IN ACCORDANCE WITH THE PROVISIONS
SET FORTH BELOW AND UNDERSTAND THAT (A) ARBITRATION IS FINAL AND BINDING ON THE PARTIES, (B) THE PARTIES ARE WAIVING THEIR RIGHTS
TO SEEK REMEDIES IN COURT, INCLUDING THE RIGHT TO A JURY TRIAL, (C) PRE-ARBITRATION DISCOVERY IS GENERALLY MORE LIMITED AND DIFFERENT
FROM COURT PROCEEDINGS, (D) THE ARBITRATOR’S AWARD IS NOT REQUIRED TO INCLUDE FACTUAL FINDINGS OR LEGAL REASONING AND ANY
PARTY’S RIGHT TO APPEAL OR TO SEEK MODIFICATION OF RULES BY ARBITRATORS IS STRICTLY LIMITED, (E) THE PANEL OF FINRA ARBITRATORS
WILL TYPICALLY INCLUDE A MINORITY OF ARBITRATORS WHO WERE OR ARE AFFILIATED WITH THE SECURITIES INDUSTRY, AND (F) ALL CONTROVERSIES
WHICH MAY ARISE BETWEEN THE PARTIES CONCERNING THIS AGREEMENT SHALL BE DETERMINED BY ARBITRATION PURSUANT TO THE RULES THEN PERTAINING
TO FINRA. ALL QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS AGREEMENT SHALL BE GOVERNED
BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. JUDGMENT ON ANY AWARD OF ANY SUCH ARBITRATION
MAY BE ENTERED IN ANY FEDERAL OR STATE COURT WITHIN
THE STATE AND COUNTY OF NEW YORK. THE PARTIES AGREE THAT THE DETERMINATION
OF THE ARBITRATORS SHALL BE BINDING AND CONCLUSIVE UPON THEM. THE PREVAILING PARTY, AS DETERMINED BY SUCH ARBITRATORS, IN A LEGAL
PROCEEDING SHALL BE ENTITLED TO COLLECT ANY COSTS, DISBURSEMENTS AND REASONABLE ATTORNEY’S FEES FROM THE OTHER PARTY. 
PRIOR TO FILING AN ARBITRATION, THE PARTIES HEREBY AGREE THAT THEY WILL ATTEMPT TO RESOLVE THEIR DIFFERENCES FIRST BY SUBMITTING
THE MATTER FOR RESOLUTION TO A MEDIATOR, ACCEPTABLE TO ALL PARTIES, AND WHOSE EXPENSES WILL BE BORNE EQUALLY BY ALL PARTIES. THE
MEDIATION WILL BE HELD IN THE COUNTY OF NEW YORK, STATE OF NEW YORK, ON AN EXPEDITED BASIS. IF THE PARTIES CANNOT SUCCESSFULLY
RESOLVE THEIR DIFFERENCES THROUGH MEDIATION, THE MATTER WILL BE RESOLVED BY ARBITRATION. THE ARBITRATION SHALL TAKE PLACE IN THE
COUNTY OF NEW YORK, THE STATE OF NEW YORK, ON AN EXPEDITED BASIS. 

 

    	Placement Agency Agreement (PIPE)	Page 22

     

    

 

14.          Miscellaneous.

 

(a)           No
provision of this Agreement may be changed or terminated except by a writing signed by the party or parties to be charged therewith.
Unless expressly so provided, no party to this Agreement will be liable for the performance of any other party’s obligations
hereunder. Either party hereto may waive compliance by the other with any of the terms, provisions and conditions set forth herein;
provided, however, that any such waiver shall be in writing specifically setting forth those provisions waived thereby. No such
waiver shall be deemed to constitute or imply waiver of any other term, provision or condition of this Agreement. Neither party
may assign its rights or obligations under this Agreement to any other person or entity without the prior written consent of the
other party.

 

(b)           Each
party shall, without payment of any additional consideration by any other party, at any time on or after the date of any Closings,
take such further action and execute such other and further documents and instruments as the other party may reasonably request
in order to provide the other party with the benefits of this Agreement.

 

(c)           The
Parties to this Agreement each hereby confirm that they will cooperate with each other to the extent that it may become necessary
to enter into any revisions or amendments to this Agreement, in the future to conform to any federal or state regulations as long
as such revisions or amendments do not materially alter the obligations or benefits of either party under this Agreement.

 

15.          Entire
Agreement; Severability. This Agreement together with any other agreement referred to herein supersedes all prior understandings
and written or oral agreements between the parties with respect to the Offering and the subject matter hereof. If any portion
of this Agreement shall be held invalid or unenforceable, then so far as is reasonable and possible (i) the remainder of this
Agreement shall be considered valid and enforceable and (ii) effect shall be given to the intent manifested by the portion held
invalid or unenforceable.

 

16.          Counterparts.
This Agreement may be executed in multiple counterparts, each of which may be executed by less than all of the parties and shall
be deemed to be an original instrument which shall be enforceable against the parties actually executing such counterparts and
all of which together shall constitute one and the same instrument. The exchange of copies of this Agreement and of signature
pages by facsimile transmission or in pdf format shall constitute effective execution and delivery of this Agreement as to the
parties and may be used in lieu of the original Agreement for all purposes. Signatures of the parties transmitted by facsimile
or in pdf format shall be deemed to be their original signatures for all purposes.

 

17.          Announcement
of Offering. The
Placement Agent and its counsel and advisors may, subsequent to the Final Closing
of any Offering, make public their involvement with the Company, including use of the Company’s trademarks and logos. The
Placement Agent’s counsel and advisors are intended third party beneficiaries of this Section.

 

18.          Advice
to the Board. The Company acknowledges that any advice given by the Placement Agent
to the Company is solely for benefit and use of the Company’s board of directors and officers, who will make all decisions
regarding whether and how to pursue any opportunity or transaction, including any potential Offering. The Company’s board
of directors and management may consider such advice, but will also base their decisions on the advice of legal, tax and other
business advisors and other factors which they consider appropriate. Accordingly, as an independent contractor, the Placement
Agent will not assume the responsibilities of a fiduciary to the Company or its stockholders in connection with the performance
of the services. Any advice provided may not be used, reproduced, disseminated, quoted or referred to without prior written consent
of the providing party. The Placement Agent does not provide accounting, tax or legal advice. The Company is a sophisticated business
enterprise that has retained the Placement Agent for the limited purposes set forth in this Agreement. The parties acknowledge
and agree that their respective rights and obligations are contractual in nature. Each party disclaims an intention to impose
fiduciary obligations on the other by virtue of the engagement contemplated by this Agreement.

 

    	Placement Agency Agreement (PIPE)	Page 23

     

    

 

19.          Other
Investment Banking Services. The Company acknowledges that
the Placement Agent and their affiliates are securities firms engaged in securities trading and brokerage activities and providing
investment banking and financial advisory services. In the ordinary course of business, the Placement Agent and their affiliates
may at any time hold long or short positions, and may trade or otherwise effect transactions, for their own account or the accounts
of customers, in the Company’s debt or equity securities, its affiliates or other entities that may be involved in the transactions
contemplated by this Agreement. In addition, the Placement Agent and their affiliates may from time to time perform various investment
banking and financial advisory services for other clients and customers who may have conflicting interests with respect to the
Company or the Offering. The Company also acknowledges that the Placement Agent and their affiliates have no obligation to use
in connection with this engagement or to furnish the Company, confidential information obtained from other companies. Furthermore,
the Company acknowledges the Placement Agent may have fiduciary or other relationships whereby their or their affiliates may exercise
voting power over securities of various persons, which securities may from time to time include securities of the Company or others
with interests in respect of any Offering. The Company acknowledges that the Placement Agent or such affiliates may exercise such
powers and otherwise perform our functions in connection with such fiduciary or other relationships without regard to the Placement
Agent’s relationship to the Company hereunder.

 

20.          Successors.
This Agreement shall inure to the benefit of and be binding upon the successors of the Placement Agent and of the Company
(including any party that acquires the Company or all or substantially all of its assets or merges with the Company). Nothing
expressed or mentioned in this Agreement is intended or shall be construed to give any person or corporation, other than the parties
hereto and parties expressly referred to herein, any legal or equitable right, remedy or claim under or in respect to this Agreement
or any provision hereof. The term “successors” shall not include any purchaser of the Securities merely by reason
of such purchase. No subrogee of a benefited party shall be entitled to any benefits hereunder. Each party hereto disclaims any
an intention to impose any fiduciary obligation on any other party by virtue of the arrangements contemplated by this Agreement.

 

[Signatures
on following page.]

 

    	Placement Agency Agreement (PIPE)	Page 24

     

    

 

If
the foregoing is in accordance with your understanding of the agreement among the Company and the Placement Agent, kindly sign
and return this Agreement, whereupon it will become a binding agreement as provided herein, between the Company and the Placement
Agent in accordance with its terms.

 

This
Agreement contains a predispute arbitration provision in paragraph 13.

 

	 	ATRINSIC INC. 
	 	 	 
	 	By: 	/s/
    Edward Gildea
	 	 	Edward
    Gildea
	 	 	Chief
    Executive Officer
	 	 	 
	 	KATALYST
    SECURITIES LLC
	 	 	 
	 	By:	/s/
    Michael A. Silverman
	 	 	Michael
    A. Silverman
	 	 	Managing
    Director

 

    	Placement Agency Agreement (PIPE)	Signature Page

     

    

 

EXHIBIT 1

 

	1.	Brandt Mandia
	2.	Greg Pappas
	3.	Danny Vaccaro
	4.	Donald Vaccaro
	5.	Joe Perri
	6.	Peter Ungaro
	7.	LMB Tech Investments LLC
	8.	Dasa Sada LLC
	9.	Michael Collado
	10.	Michael Fiumefreddo
	11.	Robert Granito
	12.	Stephanie Midgley
	13.	Carmine Desantis
	14.	Iroquois Capital Management, LLC and related entities
	15.	Hudson Bay Master Fund Ltd and related entities

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00257-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00257-of-00352.parquet"}]]